Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20040068230 A1
Publication typeApplication
Application numberUS 10/624,389
Publication date8 Apr 2004
Filing date22 Jul 2003
Priority date24 Jul 2002
Also published asEP1525014A2, EP1525014B1, EP2253346A1, EP2253347A1, US8192395, US8568357, US20090099506, US20090099509, US20090112076, US20090118664, US20090118665, US20090143662, US20090149803, US20100198143, US20120220928, WO2004008956A2, WO2004008956A3
Publication number10624389, 624389, US 2004/0068230 A1, US 2004/068230 A1, US 20040068230 A1, US 20040068230A1, US 2004068230 A1, US 2004068230A1, US-A1-20040068230, US-A1-2004068230, US2004/0068230A1, US2004/068230A1, US20040068230 A1, US20040068230A1, US2004068230 A1, US2004068230A1
InventorsMark Estes, Cary Talbot, Mike Charles Tolle, Jay Yonemoto
Original AssigneeMedtronic Minimed, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
System for providing blood glucose measurements to an infusion device
US 20040068230 A1
Abstract
An infusion system includes a characteristic determining device and an infusion device. The characteristic determining device includes a receptacle for receiving and testing an analyte from the user to determine a concentration of the analyte in the user. The characteristic determining device also includes a communication system for transmitting a communication including data indicative of the determined concentration of the analyte in the user, and the infusion device includes a communication system for receiving the communication from the characteristic determining device. The infusion device further includes a bolus estimator for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and an indicator to indicate when the estimated amount of fluid to be infused has been calculated.
Images(7)
Previous page
Next page
Claims(94)
What is claimed is:
1. An infusion system for infusing a fluid into a body of a user, the infusion system comprising:
a characteristic determining device including:
a determining device housing adapted to be carried by the user;
a receptacle coupled to the determining device housing for receiving and testing an analyte from the user to determine a concentration of the analyte in the user;
a determining device processor contained in the determining device housing and coupled to the receptacle for processing the determined concentration of the analyte from the receptacle; and
a determining device communication system contained in the determining device housing and coupled to the determining device processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user; and
an infusion device including:
an infusion device housing adapted to be carried by the user;
a drive mechanism contained in the infusion device housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user;
an infusion device communication system contained in the infusion device housing for receiving the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system;
an infusion device processor contained in the infusion device housing and coupled to the infusion device communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device;
a bolus estimator used in conjunction with the infusion device processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user-and a target concentration of the analyte in the user; and
an infusion device indicator to indicate when the estimated amount of fluid to be infused has been calculated.
2. The infusion system according to claim 1, wherein the determining device communication system automatically transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device communication system.
3. The infusion system according to claim 1, wherein the characteristic determining device further includes a user input device for inputting commands, and the determining device communication system transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device communication system in response to a command from the user input device.
4. The infusion system according to claim 1, wherein the characteristic determining device further includes an indicator to indicate a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the determining device communication system to the infusion device communication system.
5. The infusion system according to claim 1, wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes a time at which the concentration of the analyte in the user was determined.
6. The infusion system according to claim 1, wherein the determining device processor determines an amount of time that has elapsed since the concentration of the analyte in the user was determined, and wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes the elapsed amount of time.
7. The infusion system according to claim 1, wherein the determining device processor determines an amount of time that has elapsed since the concentration of the analyte in the user was determined, and causes the determining device communication system not to transmit the communication including the data indicative of the determined concentration of the analyte in the user if the elapsed amount of time exceeds a predetermined amount of time.
8. The infusion system according to claim 1, wherein the infusion device processor determines an amount of time that has elapsed since the data indicative of the determined concentration of the analyte in the user was received, and causes the bolus estimator not to calculate the estimated amount of fluid to be infused based upon the determined concentration of the analyte if the elapsed amount of time exceeds a predetermined amount of time.
9. The infusion system according to claim 1, wherein the infusion device processor determines an amount of time that has elapsed since the concentration of the analyte in the user was determined, and causes the bolus estimator not to calculate the estimated amount of fluid to be infused based upon the determined concentration of the analyte if the elapsed amount of time exceeds a predetermined amount of time.
10. The infusion system according to claim 1, wherein the determining device processor has unique identification information, and further wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes the unique identification information of the determining device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
11. The infusion system according to claim 1, wherein the infusion device processor has unique identification information, and further wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes the unique identification information of the infusion device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
12. The infusion system according to claim 1, wherein the determining device communication system is capable of being deactivated and reactivated.
13. The infusion system according to claim 12, wherein the characteristic determining device further includes a user input device for inputting commands, and further wherein the determining device communication system is capable of being deactivated in response to a first command from the user input device and being reactivated in response to a second command from the user input device.
14. The infusion system according to claim 12, wherein the characteristic determining device further includes a user input device for inputting commands, and the determining device communication system is capable of being deactivated in response to a command from the user input device, and further wherein the determining device processor causes the determining device communication system to be automatically reactivated after a predetermined amount of time has elapsed.
15. The infusion system according to claim 12, wherein the characteristic determining device further includes a user input device for inputting commands, and the determining device communication system is capable of being deactivated in response to a command from the user input device, and further wherein the determining device processor causes the determining device communication system to be automatically reactivated at a predetermined time of day.
16. The infusion system according to claim 12, wherein the characteristic determining device further includes a memory for storing data indicative of the determined concentration of the analyte in the user that is determined when the determining device communication system is deactivated, and further wherein the determining device communication system transmits a communication including the stored data to the infusion device communication system when the determining device communication system is reactivated.
17. The infusion system according to claim 1, wherein the infusion device processor uses power cycling whereby power is periodically supplied to the infusion device communication system until a communication is received from the determining device communication system, and further wherein the infusion device processor discontinues using power cycling whereby the power is continuously supplied to the infusion device communication system when a communication is received from the determining device communication system.
18. The infusion system according to claim 1, wherein the infusion device processor uses power cycling whereby power is periodically supplied to the infusion device communication system until a communication is received from the determining device communication system, and further wherein the infusion device processor discontinues using power cycling whereby the power is continuously supplied to the infusion device communication system when the communication including the data indicative of the determined concentration of the analyte in the user is received from the determining device communication system.
19. The infusion system according to claim 18, wherein the infusion device processor resumes using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system.
20. The infusion system according to claim 1, further including a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer, wherein the infusion device communication system is further capable of transmitting a communication including infusion device data to be downloaded, and the determining device communication system is further capable of receiving the communication including the infusion device data to be downloaded from the infusion device communication system, and further wherein the received infusion device data is downloaded from the characteristic determining device through the connector to the computer.
21. The infusion system according to claim 1, further including a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer, wherein the infusion device communication system is further capable of transmitting a communication including infusion device data to be downloaded, and the determining device communication system is further capable of receiving the communication including the infusion device data to be downloaded from the infusion device communication system, wherein the characteristic determining device further includes a memory for storing data, and further wherein the received infusion device data is stored in the memory of the characteristic determining device for subsequent downloading through the connector to the computer.
22. The infusion system according to claim 1, wherein the infusion device indicator further indicates when the determined concentration of the analyte in the user is above or below a predetermined level of the analyte in the user.
23. The infusion system according to claim 1, wherein the determining device communication system and the infusion device communication system communicate using one of radio frequencies and infrared frequencies.
24. The infusion system according to claim 1, wherein the concentration of the analyte in the user determined by the characteristic determining device is a blood glucose level of the user, and the fluid infused by the infusion device is insulin.
25. The infusion system according to claim 24, wherein the characteristic determining device is a blood glucose test strip meter, and the infusion device is an insulin infusion pump.
26. The infusion system according to claim 1, wherein the characteristic determining device further includes a user input device for inputting remote control commands for controlling the infusion device, and wherein the determining device communication system further transmits a communication including the remote control commands, and the infusion device communication system further receives the communication including the remote control commands from the determining device communication system, and further wherein the infusion device processor controls the infusion device in accordance with the received remote control commands.
27. The infusion system according to claim 1, wherein the infusion device further includes a user input device for inputting remote control commands for controlling the characteristic determining device, and wherein the infusion device communication system further transmits a communication including the remote control commands, and the determining device communication system further receives the communication including the remote control commands from the infusion device communication system, and further wherein the determining device processor controls the characteristic determining device in accordance with the received remote control commands.
28. The infusion system according to claim 1, wherein the determining device communication system includes one of a transmitter and a transceiver, and the infusion device communication system includes one of a receiver and a transceiver.
29. The infusion system according to claim 1, wherein the infusion device further includes a user input device for inputting an estimate of a material to be ingested by the user, and further wherein the bolus estimator includes the capability to calculate the estimated amount of fluid to be infused into the body of the user based upon the inputted estimate of the material to be ingested by the user.
30. The infusion system according to claim 29, wherein the fluid to be infused is insulin, and the material to be ingested is carbohydrates.
31. The infusion system according to claim 1, wherein the characteristic determining device further includes a lancing device coupled to the receptacle for obtaining the analyte from the user.
32. The infusion system according to claim 1, wherein the characteristic determining device further includes a determining device clock, and the infusion device further includes an infusion device clock, and wherein the infusion device communication system further transmits a communication including a time of the infusion device clock, and the determining device communication system further receives the communication including the time of the infusion device clock from the infusion device communication system, and further wherein the determining device clock is set to the received time of the infusion device clock.
33. The infusion system according to claim 1, wherein the characteristic determining device further includes a determining device clock, and the infusion device further includes an infusion device clock, and wherein the determining device communication system further transmits a communication including a time of the determining device clock, and the infusion device communication system further receives the communication including the time of the determining device clock from the determining device communication system, and further wherein the infusion device clock is set to the received time of the determining device clock.
34. The infusion system according to claim 1, wherein the infusion device further includes a memory for storing data, and further wherein the data indicative of the determined concentration of the analyte in the user received by the infusion device communication system from the determining device communication system is stored in the memory of the infusion device.
35. An infusion device for infusing a fluid into a body of a user, wherein the infusion device is capable of communicating with a characteristic determining device adapted for determining a concentration of an analyte in the user, the infusion device comprising:
a housing adapted to be carried by the user;
a drive mechanism contained in the housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user;
a communication system contained in the housing for receiving a communication from the characteristic determining device, the communication including data indicative of the determined concentration of the analyte in the user;
a processor contained in the housing and coupled to the communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device;
a bolus estimator used in conjunction with the processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user; and
an indicator to indicate when the estimated amount of fluid to be infused has been calculated.
36. The infusion device according to claim 35, wherein the communication received by the communication system from the characteristic determining device further includes a time at which the concentration of the analyte in the user was determined.
37. The infusion device according to claim 35, wherein the processor determines an amount of time that has elapsed since the data indicative of the determined concentration of the analyte in the user was received from the characteristic determining device, and causes the bolus estimator not to calculate the estimated amount of fluid to be infused based upon the determined, concentration of the analyte if the elapsed amount of time exceeds a predetermined amount of time.
38. The infusion device according to claim 35, wherein the processor has unique identification information, and further wherein the communication received by the communication system from the characteristic determining device further includes the unique identification information of the infusion device such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
39. The infusion device according to claim 35, wherein the communication received by the communication system from the characteristic determining device further includes unique identification information of the characteristic determining device such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
40. The infusion device according to claim 35, wherein the processor uses power cycling whereby power is periodically supplied to the communication system until a communication is received from the characteristic determining device, and further wherein the processor discontinues using power cycling whereby the power is continuously supplied to the communication system when the communication including data indicative of the determined concentration of the analyte in the user is received from the characteristic determining device.
41. The infusion device according to claim 40, wherein the processor resumes using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from the characteristic determining device.
42. The infusion device according to claim 35, wherein the indicator further indicates when the determined concentration of the analyte in the user is above or below a predetermined level of the analyte in the user.
43. The infusion device according to claim 35, wherein the communication system communicates with the characteristic determining device using one of radio frequencies and infrared frequencies.
44. The infusion device according to claim 35, wherein the communication system includes one of a receiver and a transceiver.
45. The infusion device according to claim 35, further comprising a user input device for inputting an estimate of a material to be ingested by the user, wherein the bolus estimator includes the capability to calculate the estimated amount of fluid to be infused into the body of the user based upon the inputted estimate of the material to be ingested by the user.
46. The infusion device according to claim 35, further comprising a clock, wherein the communication system further transmits a communication including a clock time of the infusion device to the characteristic determining device, the clock time of the infusion device being adapted for setting a clock time of the characteristic determining device.
47. The infusion device according to claim 35, further comprising a clock, wherein the communication system further receives from the characteristic determining device a communication including a clock time of the characteristic determining device, the time of the characteristic determining device being adapted for setting a clock time of the infusion device.
48. The infusion device according to claim 35, further comprising a memory for storing data, wherein the data indicative of the determined concentration of the analyte in the user received by the communication system from the characteristic determining device is stored in the memory of the infusion device.
49. A characteristic determining device for determining a concentration of an analyte in a body of a user, wherein the characteristic determining device is capable of communicating with an infusion device adapted for infusing a fluid into the body of the user and calculating an estimated amount of the fluid to be infused into the body of the user based upon the determined concentration of the analyte in the user and a target concentration of the analyte in the user, the characteristic determining device comprising:
a housing adapted to be carried by the user;
a receptacle coupled to the housing for receiving and testing an analyte from the user to determine the concentration of the analyte in the user;
a processor contained in the housing and coupled to the receptacle for processing the determined concentration of the analyte from the receptacle; and
a communication system contained in the housing and coupled to the processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user to the infusion device.
50. The characteristic determining device according to claim 49, wherein the communication system automatically transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device.
51. The characteristic determining device according to claim 49, further comprising a user input device for inputting commands, wherein the communication system transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device in response to a command from the user input device.
52. The characteristic determining device according to claim 49, further comprising an indicator to indicate a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the communication system to the infusion device.
53. The characteristic determining device according to claim 49, wherein the communication transmitted by the communication system to the infusion device further includes a time at which the concentration of the analyte in the user was determined.
54. The characteristic determining device according to claim 49, wherein the processor has unique identification information, and the communication transmitted by the communication system to the infusion device further includes the unique identification information of the processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
55. The characteristic determining device according to claim 49, wherein the communication system is capable of being deactivated and reactivated.
56. The characteristic determining device according to claim 55, further comprising a memory for storing the data indicative of the determined concentration of the analyte in the user that is determined when the communication system is deactivated, and wherein the stored data is transmitted by the communication system to the infusion device when the communication system is reactivated.
57. The characteristic determining device according to claim 49, further comprising a port adapted to receive a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer, wherein the communication system is further capable of receiving a communication including data to be downloaded from the infusion device, and further wherein the received data is downloaded from the characteristic determining device through the connector to the computer.
58. The characteristic determining device according to claim 49, further comprising:
a port adapted to receive a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer; and
a memory for storing data,
wherein the communication system is further capable of receiving a communication including data to be downloaded from the infusion device, and further wherein the received data is stored in the memory for subsequent downloading through the connector to the computer.
59. The characteristic determining device according to claim 49, wherein the communication system includes one of a transmitter and a transceiver.
60. The characteristic determining device according to claim 49, further comprising a lancing device coupled to the receptacle for obtaining the analyte from the user.
61. The characteristic determining device according to claim 49, further comprising a clock, wherein the communication system further transmits a communication including a clock time of the characteristic determining device to the infusion device, the time of the characteristic determining device being adapted for setting a clock time of the infusion device.
62. The characteristic determining device according to claim 49, further comprising a clock, wherein the communication system further receives from the infusion device a communication including a clock time of the infusion device, the clock time of the infusion device being adapted for setting a clock time of the characteristic determining device.
63. In an infusion system including a characteristic determining device and an infusion device, a method for infusing a fluid into a body of a user, the method comprising the steps of:
receiving and testing an analyte from the user to determine a concentration of the analyte in the user;
transmitting with the characteristic determining device a communication including data indicative of the determined concentration of the analyte in the user;
receiving with the infusion device the communication including the data indicative of the determined concentration of the analyte in the user;
calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user; and
indicating when the estimated amount of fluid to be infused has been calculated.
64. The method according to claim 63, wherein the communication including the data indicative of the determined concentration of the analyte in the user is automatically transmitted from the characteristic determining device to the infusion device.
65. The method according to claim 63, further comprising the step of inputting a command on the characteristic determining device, wherein the communication including the data indicative of the determined concentration of the analyte in the user is transmitted from the characteristic determining device to the infusion device in response to the inputted command.
66. The method according to claim 63, further comprising the step of indicating a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the characteristic determining device to the infusion device.
67. The method according to claim 63, wherein the communication including the data indicative of the determined concentration of the analyte in the user transmitted from the characteristic determining device to the infusion device further includes a time at which the concentration of the analyte in the user was determined.
68. The method according to claim 63, further comprising the step of determining an amount of time that has elapsed since the concentration of the analyte in the user was determined.
69. The method according to claim 63, further comprising the step of determining an amount of time that has elapsed since the communication including the data indicative of the determined concentration of the analyte in the user was received by the infusion device.
70. The method according to claim 63, further comprising the steps of:
transmitting with the infusion device a communication including data from the infusion device to be downloaded;
receiving with the characteristic determining device the communication including data from the infusion device to be downloaded; and
downloading the received data from the characteristic determining device to a computer.
71. The method according to claim 63, further comprising the step of inputting an estimate of a material to be ingested by the user, wherein the estimated amount of fluid to be infused into the body of the user is calculated further based upon the inputted estimate of the material to be ingested by the user.
72. The method according to claim 63, further comprising the steps of:
transmitting with the infusion device a communication including a clock time of the infusion device;
receiving with the characteristic determining device the communication including the clock time of the infusion device; and
setting a clock time of the characteristic determining device to the received clock time of the infusion device.
73. The method according to claim 63, further comprising the steps of:
transmitting with the characteristic determining device a communication including a clock time of the characteristic determining device;
receiving with the infusion device the communication including the clock time of the characteristic determining device; and
setting a clock time of the infusion device to the received clock time of the characteristic determining device.
74. The method according to claim 63, further comprising the step of storing in a memory of the infusion device the data indicative of the determined concentration of the analyte in the user received by the infusion device from the characteristic determining device.
75. An infusion system for infusing a fluid into a body of a user, the infusion system comprising:
a characteristic determining device including:
a determining device housing adapted to be carried by the user;
a sensor coupled to the determining device housing for determining a concentration of an analyte in the user;
a determining device processor contained in the determining device housing and coupled to the sensor for processing the determined concentration of the analyte from the sensor; and
a determining device communication system contained in the determining device housing and coupled to the determining device processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user; and
an infusion device including:
an infusion device housing adapted to be carried by the user;
a drive mechanism contained in the infusion device housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user;
an infusion device communication system contained in the infusion device housing for receiving the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system; and
an infusion device processor contained in the infusion device housing and coupled to the infusion device communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device.
76. The infusion system according to claim 75, wherein the determining device communication system automatically transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device communication system.
77. The infusion system according to claim 75, wherein the characteristic determining device further includes a user input device for inputting commands, and the determining device communication system transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device communication system in response to a command from the user input device.
78. The infusion system according to claim 75, wherein the characteristic determining device further includes an indicator to indicate a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the determining device communication system to the infusion device communication system.
79. The infusion system according to claim 75, wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes a time at which the concentration of the analyte in the user was determined.
80. The infusion system according to claim 75, wherein the infusion device further includes:
a bolus estimator used in conjunction with the infusion device processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user; and
an infusion device indicator to indicate when the estimated amount of fluid to be infused has been calculated.
81. The infusion system according to claim 80, wherein the infusion device processor determines an amount of time that has elapsed since the concentration of the analyte in the user was determined, and causes the bolus estimator not to calculate the estimated amount of fluid to be infused based upon the determined concentration of the analyte if the elapsed amount of time exceeds a predetermined amount of time.
82. The infusion system according to claim 75, wherein the determining device processor has unique identification information, and further wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes the unique identification information of the determining device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
83. The infusion system according to claim 75, wherein the infusion device processor has unique identification information, and further wherein the communication transmitted from the determining device communication system to the infusion device communication system further includes the unique identification information of the infusion device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
84. The infusion system according to claim 75, wherein the determining device communication system is capable of being deactivated and reactivated.
85. The infusion system according to claim 84, wherein the characteristic determining device further includes a memory for storing data indicative of the determined concentration of the analyte in the user that is determined when the determining device communication system is deactivated, and further wherein the determining device communication system transmits a communication including the stored data to the infusion device communication system when the determining device communication system is reactivated.
86. The infusion system according to claim 75, wherein the infusion device processor uses power cycling whereby power is periodically supplied to the infusion device communication system until a communication is received from the determining device communication system, and further wherein the infusion device processor discontinues using power cycling whereby the power is continuously supplied to the infusion device communication system when the communication including the data indicative of the determined concentration of the analyte in the user is received from the determining device communication system.
87. The infusion system according to claim 86, wherein the infusion device processor resumes using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system.
88. The infusion system according to claim 75, further including a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer, wherein the infusion device communication system is further capable of transmitting a communication including infusion device data to be downloaded, and the determining device communication system is further capable of receiving the communication including the infusion device data to be downloaded from the infusion device communication system, and further wherein the received infusion device data is downloaded from the characteristic determining device through the connector to the computer.
89. The infusion system according to claim 75, wherein the determining device communication system and the infusion device communication system communicate using one of radio frequencies and infrared frequencies.
90. The infusion system according to claim 75, wherein the concentration of the analyte in the user determined by the characteristic determining device is a blood glucose level of the user, and the fluid infused by the infusion device is insulin.
91. The infusion system according to claim 75, wherein the determining device communication system includes one of a transmitter and a transceiver, and the infusion device communication system includes one of a receiver and a transceiver.
92. The infusion system according to claim 75, wherein the characteristic determining device further includes a determining device clock, and the infusion device further includes an infusion device clock, and wherein the infusion device communication system further transmits a communication including a time of the infusion device clock, and the determining device communication system further receives the communication including the time of the infusion device clock from the infusion device communication system, and further wherein the determining device clock is set to the received time of the infusion device clock.
93. The infusion system according to claim 75, wherein the characteristic determining device further includes a determining device clock, and the infusion device further includes an infusion device clock, and wherein the determining device communication system further transmits a communication including a time of the determining device clock, and the infusion device communication system further receives the communication including the time of the determining device clock from the determining device communication system, and further wherein the infusion device clock is set to the received time of the determining device clock.
94. The infusion system according to claim 75, wherein the infusion device further includes a memory for storing data, and further wherein the data indicative of the determined concentration of the analyte in the user received by the infusion device communication system from the determining device communication system is stored in the memory of the infusion device.
Description
    RELATED APPLICATIONS
  • [0001]
    This application claims priority from U.S. Provisional Applications No. 60/398,199 filed Jul. 24, 2002 and No. 60/412,998 filed Sep. 23, 2002, which are herein incorporated by reference.
  • FIELD OF THE INVENTION
  • [0002]
    This invention relates generally to infusion systems that are used for infusing a fluid into a user, and in particular, to apparatuses and methods for providing blood glucose measurements to an infusion device.
  • BACKGROUND OF THE INVENTION
  • [0003]
    Patients with Type 1 diabetes and some patients with Type 2 diabetes use insulin to control their blood glucose (BG) level. Typically, if a patient's BG level is too high, the patient can inject a “bolus” (dose) of insulin to lower his/her BG level from its present level to a desired target level. Furthermore, patients may inject a bolus of insulin in anticipation of ingesting carbohydrates, thus heading off a sharp rise in their BG level. Patients employ various calculations to determine the amount of insulin to inject. Bolus estimation software is available for calculating an insulin bolus. Patients may use these software programs on an electronic computing device, such as a computer, the Internet, a personal digital assistant (PDA), or an insulin delivery device. Insulin delivery devices include infusion pumps, injection pens, and IV meters. The best bolus estimation software takes into account the patient's present BG level. Presently, a patient must measure his/her blood glucose using a BG measurement device, such as a test strip meter, a continuous glucose measurement system, or a hospital hemacue. BG measurement devices use various methods to measure the BG level of a patient, such as a sample of the patient's blood, a sensor in contact with a bodily fluid, an optical sensor, an enzymatic sensor, or a fluorescent sensor. When the BG measurement device has generated a BG measurement, the measurement is displayed on the BG measurement device. Then the patient may visually read the BG measurement and physically enter the BG measurement into an electronic computing device to calculate a bolus estimate. Finally, once the bolus estimate is calculated, the patient must inject the insulin bolus or program an insulin delivery device to deliver the bolus into their body. Unfortunately, this process is cumbersome and is subject to transcribing errors—for example, the patient may inaccurately enter the BG measurement that is displayed on the BG measurement device into the electronic computing device. Thus, if the BG measurement is not entered correctly, the bolus estimate is not accurate, which may lead to the delivery of an inappropriate insulin dose.
  • SUMMARY OF THE INVENTION
  • [0004]
    In preferred embodiments of the present invention, an infusion system for infusing a fluid into a body of a user includes a characteristic determining device and an infusion device. The characteristic determining device includes a housing adapted to be carried by the user, a receptacle coupled to the housing for receiving and testing an analyte from the user to determine a concentration of the analyte in the user, a processor contained in the housing and coupled to the receptacle for processing the determined concentration of the analyte from the receptacle, and a communication system contained in the housing and coupled to the processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user. In particular embodiments, the characteristic determining device may also include a lancing device coupled to the receptacle for obtaining the analyte from the user. In preferred embodiments, the infusion device includes a housing adapted to be carried by the user, a drive mechanism contained in the housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user, a communication system contained in the housing for receiving the communication including the data indicative of the determined concentration of the analyte in the user from the determining device, and a processor contained in the housing and coupled to the communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device. The infusion device further includes a bolus estimator used in conjunction with the processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and an indicator to indicate when the estimated amount of fluid to be infused has been calculated. Additionally, the infusion device may include a user input device for inputting an estimate of a material to be ingested by the user, and the bolus estimator may include the capability to calculate the estimated amount of fluid to be infused into the body of the user based upon the inputted estimate of the material to be ingested by the user. The infusion device may also include a memory for storing the data indicative of the determined concentration of the analyte in the user received by the infusion device communication system from the determining device communication system.
  • [0005]
    In particular embodiments, the characteristic determining device automatically transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device. In other particular embodiments, the characteristic determining device further includes a user input device for inputting commands, and transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device in response to a command from the user input device. In additional embodiments, the characteristic determining device further includes an indicator to indicate a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the determining device communication system to the infusion device communication system.
  • [0006]
    In some embodiments, the communication transmitted from the characteristic determining device to the infusion device further includes a time at which the concentration of the analyte in the user was determined. In additional embodiments, the processor of the characteristic determining device determines an amount of time that has elapsed since the concentration of the analyte in the user was determined, and the communication transmitted from the determining device to the infusion device further includes the elapsed amount of time. Further, the processor of the characteristic determining device may cause the communication system of the characteristic determining device not to transmit the communication including the data indicative of the determined concentration of the analyte in the user if the elapsed amount of time exceeds a predetermined amount of time. In other embodiments, the infusion device processor determines an amount of time that has elapsed since the data indicative of the determined concentration of the analyte in the user was received, and causes the bolus estimator not to calculate the estimated amount of fluid to be infused based upon the determined concentration of the analyte if the elapsed amount of time exceeds a predetermined amount of time. In still other embodiments, the processor of the infusion device determines an amount of time that has elapsed since the concentration of the analyte in the user was determined, and causes the bolus estimator not to calculate the estimated amount of fluid to be infused based upon the determined concentration of the analyte if the elapsed amount of time exceeds a predetermined amount of time.
  • [0007]
    In further embodiments, the determining device communication system is capable of being deactivated and reactivated. The characteristic determining device includes a user input device for inputting commands, and the communication system of the characteristic determining device is capable of being deactivated in response to a first command from the user input device and being reactivated in response to a second command from the user input device. Alternatively, the communication system of the characteristic determining device may be automatically reactivated after a predetermined amount of time has elapsed or at a predetermined time of day. Additionally, the characteristic determining device may include a memory for storing data indicative of the determined concentration of the analyte in the user that is determined when the determining device communication system is deactivated, and the determining device communication system may transmit a communication including the stored data to the infusion device communication system when the determining device communication system is reactivated.
  • [0008]
    In still other embodiments, the processor of the characteristic determining device has unique identification information, and the communication transmitted from the characteristic determining device to the infusion device further includes the unique identification information of the determining device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device. In yet other embodiments, the processor of the infusion device has unique identification information, and the communication transmitted from the characteristic determining device to the infusion device further includes the unique identification information of the infusion device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
  • [0009]
    In preferred embodiments, the processor of the infusion device uses power cycling whereby power is periodically supplied to the communication system of the infusion device until a communication is received from the characteristic determining device. When a communication is received from the characteristic determining device, the processor of the infusion device discontinues using power cycling whereby the power is continuously supplied to the infusion device communication system. The infusion device processor may then resume using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system.
  • [0010]
    In particular embodiments, the infusion system further includes a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer. The communication system of the infusion device is further capable of transmitting a communication including infusion device data to be downloaded, and the communication system of the characteristic determining device is further capable of receiving the communication including the infusion device data to be downloaded from the infusion device. The received infusion device data is then downloaded from the characteristic determining device through the connector to the computer. Alternatively, the characteristic determining device may further include a memory for storing data, and the received infusion device data may be stored in the memory of the characteristic determining device for subsequent downloading through the connector to the computer.
  • [0011]
    In other particular embodiments, the characteristic determining device further includes a user input device for inputting remote control commands for controlling the infusion device. The communication system of the characteristic determining device further transmits a communication including the remote control commands, and the communication system of the infusion device further receives the communication including the remote control commands from the characteristic determining device. The processor of the infusion device then controls the infusion device in accordance with the received remote control commands.
  • [0012]
    In yet other particular embodiments, the infusion device further includes a user input device for inputting remote control commands for controlling the characteristic determining device. The communication system of the infusion device further transmits a communication including the remote control commands, and the communication system of the characteristic determining device further receives the communication including the remote control commands from the infusion device. The processor of the characteristic determining device then controls the characteristic determining device in accordance with the received remote control commands.
  • [0013]
    In additional embodiments, the characteristic determining device further includes a determining device clock, and the infusion device further includes an infusion device clock. The infusion device communication system further transmits a communication including a time of the infusion device clock, and the determining device communication system further receives the communication including the time of the infusion device clock from the infusion device communication system. The determining device clock is then set to the received time of the infusion device clock. Alternatively, the determining device communication system further transmits a communication including a time of the determining device clock, and the infusion device communication system further receives the communication including the time of the determining device clock from the determining device communication system. The infusion device clock is then set to the received time of the determining device clock.
  • [0014]
    In accordance with another embodiment of the present invention, an infusion device infuses a fluid into a body of a user and is capable of communicating with a characteristic determining device, which is adapted for determining a concentration of an analyte in the user. The infusion device includes a housing adapted to be carried by the user, a drive mechanism contained in the housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user, a communication system contained in the housing for receiving a communication including data indicative of the determined concentration of the analyte in the user from the characteristic determining device, and a processor contained in the housing and coupled to the communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device. The infusion device also includes a bolus estimator used in conjunction with the processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user. The infusion device further includes an indicator to indicate when the estimated amount of fluid to be infused has been calculated.
  • [0015]
    In accordance with still another embodiment of the present invention, a characteristic determining device determines a concentration of an analyte in a body of a user and is capable of communicating with an infusion device, which is adapted for infusing a fluid into the body of the user and calculating an estimated amount of the fluid to be infused into the body of the user based upon the determined concentration of the analyte in the user and a target concentration of the analyte in the user. The characteristic determining device includes a housing adapted to be carried by the user, a receptacle coupled to the housing for receiving and testing an analyte from the user to determine the concentration of the analyte in the user, a processor contained in the housing and coupled to the receptacle for processing the determined concentration of the analyte from the receptacle, and a communication system contained in the housing and coupled to the processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user to the infusion device.
  • [0016]
    According to yet another embodiment of the present invention, an infusion system includes a characteristic determining device and an infusion device, and a method for infusing a fluid into a body of a user is provided. The method includes the steps of: receiving and testing an analyte from the user to determine a concentration of the analyte in the user, transmitting with the characteristic determining device a communication including data indicative of the determined concentration of the analyte in the user, and receiving with the infusion device the communication including the data indicative of the determined concentration of the analyte in the user. The data indicative of the determined concentration of the analyte in the user received by the infusion device from the characteristic determining device may then be stored in a memory of the infusion device. The method further includes the steps of calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and indicating when the estimated amount of fluid to be infused has been calculated. Additionally, the method may include the step of inputting an estimate of a material to be ingested by the user, and the estimated amount of fluid to be infused into the body of the user is calculated further based upon the inputted estimate of the material to be ingested by the user.
  • [0017]
    In some embodiments, the communication including the data indicative of the determined concentration of the analyte in the user is automatically transmitted from the characteristic determining device to the infusion device. In other embodiments, the communication including the data indicative of the determined concentration of the analyte in the user is transmitted from the characteristic determining device to the infusion device in response to an inputted command. In still other embodiments, the system indicates a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the characteristic determining device to the infusion device.
  • [0018]
    In particular embodiments, the communication including the data indicative of the determined concentration of the analyte in the user transmitted from the characteristic determining device to the infusion device further includes a time at which the concentration of the analyte in the user was determined. In other particular embodiments, the system also determines an amount of time that has elapsed since the concentration of the analyte in the user was determined. In yet other particular embodiments, the system determines an amount of time that has elapsed since the communication including the data indicative of the determined concentration of the analyte in the user was received by the infusion device.
  • [0019]
    In additional embodiments, the method further includes the steps of transmitting with the infusion device a communication including a clock time of the infusion device, receiving with the characteristic determining device the communication including the clock time of the infusion device, and setting a clock time of the characteristic determining device to the received clock time of the infusion device. Alternatively, the method may include the steps of transmitting with the characteristic determining device a communication including a clock time of the characteristic determining device, receiving with the infusion device the communication including the clock time of the characteristic determining device, and setting a clock time of the infusion device to the received clock time of the characteristic determining device.
  • [0020]
    In accordance with a further embodiment of the present invention, an infusion system for infusing a fluid into a body of a user includes a characteristic determining device and an infusion device. The characteristic determining device includes a determining device housing adapted to be carried by the user, a sensor coupled to the determining device housing for determining a concentration of an analyte in the user, a determining device processor contained in the determining device housing and coupled to the sensor for processing the determined concentration of the analyte from the sensor, and a determining device communication system contained in the determining device housing and coupled to the determining device processor for transmitting a communication including data indicative of the determined concentration of the analyte in the user. The infusion device includes an infusion device housing adapted to be carried by the user, a drive mechanism contained in the infusion device housing and operatively coupled with a reservoir containing the fluid for infusing the fluid into the body of the user, an infusion device communication system contained in the infusion device housing for receiving the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system, and an infusion device processor contained in the infusion device housing and coupled to the infusion device communication system for processing the data indicative of the determined concentration of the analyte in the user and controlling the infusion device.
  • [0021]
    In particular embodiments, the determining device communication system automatically transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device communication system. In other particular embodiments, the characteristic determining device further includes a user input device for inputting commands, and the determining device communication system transmits the communication including the data indicative of the determined concentration of the analyte in the user to the infusion device communication system in response to a command from the user input device. In further particular embodiments, the characteristic determining device includes an indicator to indicate a status of the communication including the data indicative of the determined concentration of the analyte in the user being transmitted from the determining device communication system to the infusion device communication system.
  • [0022]
    In some embodiments, the infusion device further includes a bolus estimator used in conjunction with the infusion device processor for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user. The infusion device also includes an infusion device indicator to indicate when the estimated amount of fluid to be infused has been calculated. In other embodiments, the infusion device further includes a memory for storing data, and the data indicative of the determined concentration of the analyte in the user received by the infusion device communication system from the determining device communication system is stored in the memory of the infusion device.
  • [0023]
    In additional embodiments, the determining device processor has unique identification information, and the communication transmitted from the determining device communication system to the infusion device communication system further includes the unique identification information of the determining device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device. In yet additional embodiments, the infusion device processor has unique identification information, and the communication transmitted from the determining device communication system to the infusion device communication system further includes the unique identification information of the infusion device processor such that the infusion device is capable of discerning whether the communication is intended for receipt by the infusion device.
  • [0024]
    In further embodiments, the determining device communication system is capable of being deactivated and reactivated. The characteristic determining device may also include a memory for storing data indicative of the determined concentration of the analyte in the user that is determined when the determining device communication system is deactivated. The determining device communication system then transmits a communication including the stored data to the infusion device communication system when the determining device communication system is reactivated.
  • [0025]
    In still further embodiments, the infusion device processor uses power cycling whereby power is periodically supplied to the infusion device communication system until a communication is received from the determining device communication system. The infusion device processor discontinues using power cycling whereby the power is continuously supplied to the infusion device communication system when the communication including the data indicative of the determined concentration of the analyte in the user is received from the determining device communication system. Further, the infusion device processor resumes using power cycling upon completing the receipt of the communication including the data indicative of the determined concentration of the analyte in the user from the determining device communication system.
  • [0026]
    In other embodiments, the infusion system further includes a connector for coupling the characteristic determining device to a computer and downloading data from the characteristic determining device to the computer. The infusion device communication system is further capable of transmitting a communication including infusion device data to be downloaded, and the determining device communication system is further capable of receiving the communication including the infusion device data to be downloaded from the infusion device communication system. The received infusion device data is then downloaded from the characteristic determining device through the connector to the computer.
  • [0027]
    In yet other embodiments, the characteristic determining device further includes a determining device clock, and the infusion device further includes an infusion device clock. The infusion device communication system further transmits a communication including a time of the infusion device clock, and the determining device communication system further receives the communication including the time of the infusion device clock from the infusion device communication system. The determining device clock is then set to the received time of the infusion device clock. Alternatively, the determining device communication system further transmits a communication including a time of the determining device clock, and the infusion device communication system further receives the communication including the time of the determining device clock from the determining device communication system. The infusion device clock is then set to the received time of the determining device clock.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0028]
    A detailed description of embodiments of the invention will be made with reference to the accompanying drawings, wherein like numerals designate corresponding parts in the several figures.
  • [0029]
    [0029]FIG. 1 is a perspective view of a blood glucose meter and an infusion pump in accordance with an embodiment of the present invention.
  • [0030]
    [0030]FIG. 2 is a simplified block diagram of an infusion pump in accordance with an embodiment of the present invention.
  • [0031]
    [0031]FIG. 3(a) is a block diagram of an RF communication system in the infusion pump in accordance with an embodiment of the present invention.
  • [0032]
    [0032]FIG. 3(b) is a block diagram of an RF communication system in the infusion pump in accordance with another embodiment of the present invention.
  • [0033]
    [0033]FIG. 4(a) is a simplified block diagram of a blood glucose meter in accordance with an embodiment of the present invention.
  • [0034]
    [0034]FIG. 4(b) is a simplified block diagram of a blood glucose meter in accordance with another embodiment of the present invention.
  • [0035]
    [0035]FIG. 5 is a simplified block diagram of a blood glucose meter in accordance with still another embodiment of the present invention.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • [0036]
    As shown in the drawings for purposes of illustration, the invention is embodied in a system for communicating blood glucose measurements from a blood glucose measurement device to an electronic computing device, which utilizes the blood glucose measurements to calculate a bolus estimate. In preferred embodiments, the blood glucose (BG) measurement device is a blood glucose (BG) test strip meter, and the electronic computing device is an insulin delivery device, preferably an external insulin infusion pump. The BG meter utilizes a test strip with a sample of the user's blood to measure the user's BG level, and then transmits the BG measurement to the infusion pump using a communication system that includes, for example, a radio frequency (RF) transmitter or transceiver. The infusion pump receives the BG measurement from the BG meter, and includes bolus estimation software to calculate a bolus estimate using the received BG measurement. The infusion pump may then deliver a bolus amount to the user based on the calculated bolus estimate. Transmission of the BG measurement from the BG meter to the infusion pump eliminates user transcription errors (i.e., the user may not accurately enter the BG measurement into the infusion pump) and simplifies the use of a bolus estimator. In particular embodiments, the BG meter may also function as a remote controller for the infusion pump, so the user can initiate a bolus delivery (without the bolus estimator) or stop a bolus delivery using buttons located on the BG meter. The BG meter may further function as a communications link for downloading data from the infusion pump to a computer or the like.
  • [0037]
    However, in alternative embodiments of the present invention, the BG measurement device may be a continuous glucose measurement system, a hospital hemacue, an automated intermittent blood glucose measurement system, and the like, and/or the BG measurement device may use other methods for measuring the user's BG level, such as a sensor in contact with a body fluid, an optical sensor, an enzymatic sensor, a fluorescent sensor, a blood sample placed in a receptacle, or the like. In further alternative embodiments, the electronic computing device may be another type of insulin delivery device, such as an implantable insulin infusion pump or system that uses a combination of implantable and external components, an injection pen, an IV meter, and the like. In other alternative embodiments, the electronic computing device may be a computer, the Internet, a personal digital assistant (PDA), a portable telephone, a custom computing device, and the like. In still further alternative embodiments, the BG measurement device may use samples from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like. In yet other alternative embodiments, other measurement devices may be utilized to determine the concentrations, levels, or quantities of other characteristics, analytes, or agents in the user, such as hormones, cholesterol, oxygen, pH, lactate, heart rate, respiratory rate, medication concentrations, viral loads (e.g., HIV), or the like. In still other alternative embodiments, other fluids may be delivered to the user, such as medication other than insulin (e.g., HIV drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, and anti-cancer treatments), chemicals, enzymes, antigens, hormones, vitamins, or the like. Particular embodiments are directed towards the use in humans; however, in alternative embodiments, the infusion devices may be used in animals.
  • [0038]
    In preferred embodiments of the present invention, a blood glucose (BG) measurement device measures a user's BG level and then communicates the BG measurement to an electronic computing device, which utilizes the BG measurement to calculate a bolus estimate. In the embodiment illustrated in FIG. 1, the BG measurement device is a BG test strip meter 10, and the electronic computing device is an insulin delivery device, preferably an external insulin infusion pump 50.
  • [0039]
    Referring to FIGS. 1 and 4(a), a housing 13 of the BG meter 10 preferably includes a test strip receptacle or port 11 for receiving and analyzing a test strip 12 or the like with a sample of the user's blood 14 on the test strip 12 to obtain a BG measurement. The BG meter 10 is adapted to be carried by the user, for example, in the hand, on the body, in a clothing pocket, attached to clothing (e.g., using a clip, strap, adhesive, or fastener), and the like. In particular embodiments, the user may utilize a separate lancing device (not shown) to obtain a blood sample, and then apply the sample onto the test strip 12. In other particular embodiments, the BG meter 10 may incorporate a lancing device (not shown) that obtains and automatically applies the blood sample onto the test strip 12.
  • [0040]
    In alternative embodiments, the BG measurement device may be a continuous glucose measurement system, a hospital hemacue, an automated intermittent blood glucose measurement system, and the like, and/or the BG measurement device may use other methods for measuring the user's BG level, such as a sensor in contact with a body fluid, an optical sensor, an enzymatic sensor, a fluorescent sensor, a blood sample placed in a receptacle, or the like. The BG measurement device may generally be of the type and/or include features disclosed in U.S. patent application Ser. No. 09/377,472 filed Aug. 19, 1999 and entitled “Telemetered Characteristic Monitor System and Method of Using the Same,” Ser. No. 09/334,996 filed Jun. 17, 1999 and entitled “Characteristic Monitor with a Characteristic Meter and Method of Using the Same,” Ser. No. 09/487,423 filed Jan. 20, 2000 and entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same,” and Ser. No. 09/935,827 filed Aug. 23, 2001 and entitled “Handheld Personal Data Assistant (PDA) with a Medical Device and Method of Using the Same,” which are herein incorporated by reference. Such BG measurement devices may be adapted to be carried by the user, for example, in the hand, on the body, in a clothing pocket, attached to clothing (e.g., using a clip, strap, adhesive, or fastener), and the like. In further alternative embodiments, the BG measurement device may use samples from body fluids other than blood, such as interstitial fluid, spinal fluid, saliva, urine, tears, sweat, or the like. In yet other alternative embodiments, other characteristic determining or measuring devices may be utilized to determine or measure the concentrations, levels, or quantities of other characteristics, analytes, or agents in the user, such as hormones, cholesterol, oxygen, pH, lactate, heart rate, respiratory rate, medication concentrations, viral loads (e.g., HIV), or the like.
  • [0041]
    In particular embodiments, once the BG meter 10 obtains a BG measurement, the BG measurement is transmitted to the infusion pump 50 using a communication system, which includes a radio frequency (RF) transmitter 15, as will be described below. In other particular embodiments, the RF transmitter 15 may be replaced with an RF transceiver 19 (as shown in FIG. 4(b)) or 36 (as shown in FIG. 5), and the BG measurement may be transmitted to the infusion pump 50 using the RF transceiver 19 or 36.
  • [0042]
    The test strip port 11 and RF transmitter 15 are coupled to a processor 17 contained in the housing 13 of the BG meter 10. The processor 17 runs programs and controls the BG meter 10, and is also connected to a memory 30 for storing programs, history data, user defined information and parameters, and the like. The BG meter 10 also preferably includes a display 16 for providing the BG measurement and/or messages, such as status or error messages, to the user. In particular embodiments, the display 16 may include a backlight for reading the display 16 in the dark.
  • [0043]
    In preferred embodiments, the BG meter 10 includes one or more buttons 18 and 20 for operation of the meter 10, such as turning on/off the meter 10, reviewing previous BG measurements, transmitting BG measurements to the infusion pump 50, turning off the transmitter 15 (or transceiver 19 (shown in FIG. 4(b)) or 36 (shown in FIG. 5)) in the BG meter 10 so that it does not send a BG measurement to the infusion pump 50, and the like. The BG meter 10 may further include a keypad 28 with one or more buttons 22, 24, and 26 that are preferably dedicated to remotely controlling the infusion pump 50, for example, via the RF transmitter 15 (or RF transceiver 19 (as shown in FIG. 4(b)) or 36 (as shown in FIG. 5)), as will be described below. The buttons 22, 24, and 26 may also be used to transmit BG measurements to the infusion pump 50. The buttons 22, 24, and 26 may be labeled ‘S’ for “suspend”, ‘B’ for “bolus”, and ‘ACT’ for “activate”. In alternative embodiments, more or less buttons for operating the meter 10 and/or remotely controlling the infusion pump 50 may be included on the meter 10, and the buttons may be labeled other than as illustrated in FIG. 1. For example, the BG meter 10 may include an additional button for operating a lancing device (not shown) that is incorporated into the meter 10. In further alternative embodiments, the buttons 22, 24, and 26 may be omitted, and the buttons 18 and 20 may be used to remotely control the infusion pump 50. In other alternative embodiments, the buttons 18 and 20 may be omitted, and the buttons 22, 24, and 26 may be used to operate the BG meter 10, or alternatively, no buttons may be needed to operate the meter 10. For example, the meter 10 may include no buttons or other user interface or input device, and may be controlled using an external device, such as a remote programmer (not shown), the infusion pump 50, a PDA, or the like. In yet other alternative embodiments, one or more of the buttons 18, 20, 22, 24, and 26 may be omitted, and the user may utilize other input devices to interface with the BG meter 10, such as selecting a menu item, utilizing the display 16 as a touch screen, pressing multi-function keys, or the like.
  • [0044]
    In addition to transmitting the BG measurement to the infusion pump 50, the BG meter 10 also preferably stores the BG measurement in the memory 30 of the BG meter 10 for subsequent analysis and review. A history of alarms or error messages generated by the BG meter 10, as well as remote control commands sent to and/or information received from the infusion pump 50, may also be stored in the memory 30 of the BG meter 10. Further, the user may periodically cause the BG meter 10 to download the stored data through an interface (such as the RF transmitter 15 (or RF transceiver 19 (as shown in FIG. 4(b)) or 36 (as shown in FIG. 5)), a cable, a communication station, or the like), to a computer 34, or alternatively, over the Internet to a remote server for storage. In particular embodiments, a connector 32 may be inserted into the test strip port 11 to provide a wired connection to a USB, serial, or the like port of the computer 34, and data may be downloaded from the BG meter 10 through the connector 32 to the computer 34. The user or a caregiver (e.g., the user's parent, health care professional, educator) can evaluate the user's therapy by accessing the historical BG measurements and insulin delivery information downloaded from the pump 50, as will be described below.
  • [0045]
    In the embodiment illustrated in FIGS. 1 and 2, the electronic computing device is an insulin delivery device, preferably an external insulin infusion pump 50. The infusion pump 50 regulates the flow of fluid from the infusion pump 50, through a flexible tube 54, and into an infusion set 56 or the like that is adhered to the individual. Infusion sets 56 that may be used as a delivery device are described in, but not limited to, U.S. Pat. Nos. 4,723,947; 4,755,173; 5,176,662; 5,584,813; and 6,056,718, which are herein incorporated by reference. The infusion pump 50 may be of the type described in U.S. Pat. Nos. 4,562,751; 4,685,903; 5,080,653; 5,097,122; 5,505,709; and 6,248,093; and disclosed in U.S. patent application Ser. No. 09/334,858 (attorney docket PD-0294), filed Jun. 17, 1999 and entitled “Infusion Pump With Remote Programming and Carbohydrate Calculator Capabilities,” which are herein incorporated by reference. Such infusion pumps 50 may be adapted to be carried by the user, for example, in the hand, on the body, in a clothing pocket, attached to clothing (e.g., using a clip, strap, adhesive, or fastener), and the like. Alternatively, other infusion pumps 50 may be used for delivery of fluid through an infusion set 56 into an individual's body. In further alternative embodiments, devices other than infusion pumps 50 may be used for delivery of fluid into an individual's body, such as an implantable insulin infusion pump or system that uses a combination of implantable and external components, an injection pen, an IV meter, and the like. In other alternative embodiments, the electronic computing device may be a computer, the Internet, a personal digital assistant (PDA), a portable telephone, a custom computing device, and the like.
  • [0046]
    As illustrated in FIGS. 1 and 2, preferred embodiments of the infusion pump 50 include an RF communication system 60 and a bolus estimator 62. In particular embodiments, the RF communication system 60 includes an RF receiver 80, as shown in FIG. 3(a), which allows one-way communication from the BG meter 10 (or other external devices such as a remote programmer for the infusion pump 50) to the infusion pump 50. In other particular embodiments, the RF communication system 60′ may include an RF transceiver 81, as shown in FIG. 3(b), which allows two-way communication between the BG meter 10 (or other external devices such as a remote programmer for the infusion pump 50) and the infusion pump 50.
  • [0047]
    The RF communication system 60 and bolus estimator 62 communicate with a processor 64 contained in a housing 52 of the infusion pump 50. The processor 64 is used to run programs and control the infusion pump 50, and is connected to an internal memory device 66 that stores programs, history data, user defined information and parameters. In preferred embodiments, the memory device 66 is a ROM and DRAM; however, in alternative embodiments, the memory device 66 may include other memory storage devices, such as RAM, EPROM, dynamic storage such as flash memory, energy efficient hard-drive, or the like. In the illustrated embodiment, the processor 64 is also coupled to a drive mechanism 72 that is connected to a fluid reservoir 74 containing fluid, which is delivered through an outlet 76 in the reservoir 74 and housing 52, and then into the user's body through the tubing 54 and the infusion set 56.
  • [0048]
    The infusion pump 50 is preferably programmed through a user input device such as a keypad 58 on the housing 52, or alternatively, by commands received from an RF programmer (not shown) through the RF communication system 60. The infusion pump 50 may also be programmed through the keypad 58 on the BG meter 10, for example, through the RF communication system 60, as will be described below. Feedback to the infusion pump 50 on status or programming changes are shown on a display 68, audibly through a speaker 70, and/or tactilely through a vibration alarm 78. The infusion pump 50 may also provide the user with an alarm either audibly via the speaker 70 and/or tactilely via the vibration alarm 78, such as a warning that is indicative of a low reservoir situation or low battery. Alarms may start out at a low level and escalate until acknowledged by the user. In alternative embodiments, the keypad 58 may include more or less keys or different key arrangements than those illustrated in FIG. 1. In further alternative embodiments, the keypad 58 may be omitted, and the display 68 may be used as a touch screen input device. In other alternative embodiments, the keypad 58, display 68, speaker 70, and/or vibration alarm 78 may be omitted, and all programming and data transfer may be handled through the RF communication system 60.
  • [0049]
    In particular embodiments, one-way communication is provided from the BG meter 10 to the infusion pump 50. The BG meter 10 includes the RF transmitter 15 (shown in FIG. 4(a)), and the infusion pump 50 includes an RF receiver 80 (shown in FIG. 3(a)). In other particular embodiments, two-way communication is provided between the BG meter 10 and the infusion pump 50. The RF transmitter 15 in the BG meter 10 is replaced with an RF transceiver 19 (shown in FIG. 4(b)) or 36 (shown in FIG. 5), and the RF receiver 80 in the infusion pump 50 is replaced with an RF transceiver 81 (shown in FIG. 3(b)).
  • [0050]
    The infusion pump 50 may provide several programming options, including the bolus estimator 62, as well as remote and on-device programming. The infusion pump 50 may also be configured through an interface, such as a cable or communication station, using a computer or the like. Additionally, the infusion pump 50 may allow the user to download information in the memory 66 through the interface to a computer or the like, or alternatively, over the Internet to a remote server, for storage. Further description of a communication station of this general type may be found in U.S. Pat. No. 5,376,070, which is herein incorporated by reference. The user or a caregiver (e.g., the user's parent, health care professional, educator) can evaluate the user's therapy by accessing the historical BG measurements downloaded from the BG meter 10 and insulin delivery information downloaded from the pump 50.
  • [0051]
    Information may also be downloaded from the infusion pump 50 through the RF communication system 60. Referring to FIG. 3(b), the RF communication system 60′ may include the RF transceiver 81 for transmitting information to and receiving information from external devices. In particular embodiments, an external communication link (not shown) may be connected to a serial, USB, or the like port of a computer. Information may be transmitted from the RF transceiver 81 in the infusion pump 50 to an RF transceiver in the external communication link (not shown), which then downloads the information through a wired connection to the computer or the like. During the download process, the communication link may draw power from the computer through the serial, USB, or the like port. In other particular embodiments, the connector 32 may be inserted into the test strip port of the BG meter 10′ to provide a wired connection to a USB, serial, or the like port of the computer 34, as shown in FIG. 4(b). Information may be transmitted from the RF transceiver 81 in the infusion pump 50 to the RF transceiver 19 in the BG meter 10′, and may then be downloaded through the connector 32 to the computer 34. The BG meter 10′ merely functions as a “pass through” connection between the infusion pump 50 and the computer 34. During the download process, power may be drawn from the power supply (not shown) for the BG meter 10′ (e.g., battery or the like), or alternatively, from the USB, serial, or the like port of the computer 34. In still other particular embodiments, information may be transmitted from the RF transceiver 81 in the infusion pump 50 to the RF transceiver 36 in the BG meter 10″, as shown in FIG. 5. The information may be transmitted from the infusion pump 50 to the BG meter 10″ at a rate higher than can be handled by the meter processor 17″. Accordingly, the BG meter 10″ may include a communications microcontroller or processor 38 with a higher processing speed (e.g., 10 MHz) than the meter processor 17″ with a lower processing speed (e.g., 1-4 MHz). The transmitted information is first processed by the communications processor 38, then processed by the meter processor 17″, and finally downloaded through the connector 32 to the computer 34. Again, the BG meter 10′ merely functions as a “pass through” connection between the infusion pump 50 and the computer 34. In alternative embodiments, information may be transmitted from the infusion pump 50 and stored in the memory 30′ or 30″ of the BG meter 10′ or 10″ for subsequent downloading from the BG meter 10′ or 10″ to the computer 34. In further alternative embodiments, information may be transmitted from the infusion pump 50 through the BG meter to the computer 34 using other modes of communication, such as infrared, optical, or the like.
  • [0052]
    In preferred embodiments, the infusion pump 50 communicates with various external devices, such as the BG meter 10, a remote programmer, and a communication station, using the RF communication system 60, which will be described below. The infusion pump 50 also provides a confirmation to the user upon receipt of a communication from another device (e.g., the BG meter 10). In particular embodiments, the infusion pump 50 provides one or more audible signals when it has received a communication. More than one audible signal may be used, and each audible signal indicates the type of communication that was received. For example, the infusion pump 50 may beep 4 times when it has received a communication to deliver 0.4 units of insulin in a bolus, provide a long low tone when it has received a communication to suspend insulin delivery, and/or sound off with a two-tone “door bell” sound when a new BG measurement has been communicated. In alternative embodiments, the infusion pump 50 may provide other forms of confirmation when a communication has been received, such as one or more vibrations via the vibration alarm 78, messages on the display 68, lights or flashing lights, or the like.
  • [0053]
    In preferred embodiments, once the BG meter 10 obtains a BG measurement, the BG meter 10 automatically transmits the BG measurement to the infusion pump 50. In particular embodiments, the BG meter 10 analyzes the blood sample 14 on the test strip 12 to calculate a BG measurement and then transmits the BG measurement to the infusion pump 50 without additional effort by the user. In alternative embodiments, the BG measurement is transmitted when the test strip 12 is removed from the BG meter 10. In other alternative embodiments, the BG meter 10 transmits the BG measurement in response to an action by the user. The BG meter 10 may also retransmit the BG measurement to the infusion pump 50 in response to a user action, such as pressing a button, selecting a menu item, or holding down a button on the BG meter 10, aligning the BG meter 10 and the infusion pump 50, or the like. In alternative embodiments, the BG meter 10 is notified by the infusion pump 50 to transmit or retransmit the BG measurement.
  • [0054]
    Once the infusion pump 50 receives the BG measurement, the infusion pump 50 may provide an alarm or warning to the user if the received BG measurement is above or below glycemic limits. The glycemic limits are preferably programmable, such as 120 mg/dl for hyperglycemia and 60 mg/dl for hypoglycemia. The user, a caregiver, a physician, a parent, a guardian, a child, or the like may program other limits into the infusion pump 50. In alternative embodiments, the glycemic limits are not programmable. In preferred embodiments, the infusion pump 50 will suspend insulin delivery if the received BG measurement is below the hypoglycemic limit. The infusion pump 50 may also notify the user to activate a bolus delivery if the received BG measurement is above the hyperglycemic limit. In alternative embodiments, the infusion pump 50 does not compare the received BG measurement to glycemic limits, and does not suspend insulin delivery in the event of hypoglycemia or notify the user to activate bolus delivery in the event of hyperglycemia.
  • [0055]
    In preferred embodiments, the infusion pump 50 also stores the received BG measurement in its memory 66. Further, the bolus estimator 62 in the infusion pump 50 may utilize the received BG measurement to calculate a bolus estimate, either automatically or in response to user input, such as through the keypad 58, a remote programmer, or the like. Once the bolus estimate is calculated and provided to the user, for example, on the display 68, the user may then approve the recommended estimate for delivery into the body, modify the recommended estimate for delivery into the body, or reject the recommended estimate. The bolus estimator 62 may generally be of the type and/or include features disclosed in U.S. patent application Ser. No. 09/334,858 filed Jun. 16, 1999, now issued U.S. Pat. No. 6,554,798 issued Apr. 29, 2003.
  • [0056]
    The BG meter 10 preferably informs the user of the status of the BG measurement calculation and/or transmission. If the infusion pump 50 is capable of only one-way communication, such notification is preferable because no confirmation is received from the infusion pump 50 indicating that the transmitted data has been received by the pump 50. The BG meter 10 may notify the user when a blood sample is being analyzed to obtain a BG measurement. The BG meter 10 may also notify the user when the BG measurement is being transmitted to the infusion pump 50. The BG meter 10 may further notify the user when the transmission of the BG measurement is complete. Once notified that the transmission of the BG measurement is complete, the user may access the bolus estimator 62 in the infusion pump 50 to view the BG measurement and calculate a bolus. In preferred embodiments, the BG meter 10 displays the status on the display 16, for example, as an alphanumeric message, a graphical icon, or the like. In alternative embodiments, the status is communicated to the user in other ways, such as using one or more light emitting diodes, one or more audible tones, a speaker, a piezo electric device, a vibrator or other tactile device, or the like. In further alternative embodiments, the BG meter 10 may not provide the status to the user. For example, if the BG measurement device provides continuous or automatic intermittent BG measurements, the user is not perpetually notified regarding the status of the calculations and/or transmissions.
  • [0057]
    In preferred embodiments, the BG meter 10 keeps track of the elapsed time between when a BG measurement is collected and when it is communicated to the infusion pump 50 for calculating a bolus estimate. A BG measurement is preferably used to calculate a bolus estimate only if the BG measurement is recent enough. The bolus estimation is at least partially dependent on the difference between the user's present BG level and a desired target BG level. Since a user's BG level varies over time, using an old BG measurement to calculate a bolus estimation might result in a bolus estimation that is inappropriate for the user. A BG measurement is expired (and is not used for bolus estimation) when it is too old to be considered representative of the user's present BG level. The BG meter 10 does not transmit a BG measurement to the infusion pump 50 for use in a bolus estimation calculation if the BG measurement is expired. The BG meter 10 may also indicate to the user that a new BG measurement is required because the BG measurement is expired or unavailable. In preferred embodiments, the BG measurement expires at 10 minutes. In alternative embodiments, the BG measurement may expire in an amount of time greater or less than 10 minutes, such as 5 or 7 minutes, 15 or 30 minutes, 1 hour, or the like. In further alternative embodiments, the time required for a BG measurement to expire may be set by the user, a caregiver, a physician, a parent, a guardian, a child, and the like. For example, a child's BG level may change more quickly than that of a heavy adult, so the BG meter 10 may be set so that BG measurements older than 5 minutes cannot be communicated to the infusion pump 50 for use in a bolus estimation. To continue the example, an adult might program the BG meter 10 so that BG measurements expire after 12 minutes. Furthermore, the time required for a BG measurement to expire may be set depending on the time of the user's most recent bolus dose of medication. A first period may be set if the user has taken a bolus within a specified duration of time, and a second period may be set if the user has not taken a bolus within the specified duration of time. For example, the time required for a BG measurement to expire may be set to 5 minutes if the user has taken a bolus within the past 2 hours, and to 15 minutes if the user has not taken a bolus within the past 2 hours.
  • [0058]
    In preferred embodiments, the infusion pump 50 does not use an expired BG measurement in a bolus estimation calculation. The infusion pump 50 preferably keeps track of the time between when a new BG measurement is received from the BG meter 10 and when the new BG measurement is used in a bolus estimation calculation. In particular embodiments, once the BG meter 10 obtains a BG measurement, the BG measurement is immediately transmitted to the infusion pump 50, either automatically or in response to a user action. Thus, when the infusion pump 50 receives a BG measurement, the pump 50 knows that the BG measurement was recent, and can calculate the approximate age of the BG measurement simply by determining the amount of time that has elapsed between when the BG measurement was received from the BG meter 10 and when the BG measurement is used in a bolus estimation calculation. In other particular embodiments, the infusion pump 50 is told the age of the BG measurements it receives. In other words, the elapsed time between when a BG measurement is collected and when it is communicated to the infusion pump 50 is transmitted along with each BG measurement. Then, the infusion pump 50 can calculate the age of the BG measurement by adding the age of BG measurement at the time it was transmitted to the time that has passed since the BG measurement was received. Since the infusion pump 50 knows the age of the BG measurement, the infusion pump 50 can eliminate BG measurements that are expired and/or prevent expired BG measurements from being used in a bolus estimation calculation. In particular embodiments, the infusion pump 50 will request a new BG measurement from the user when the user attempts to use a bolus estimator and the BG measurement is expired or unavailable.
  • [0059]
    In alternative embodiments, an estimate of the user's BG level is used for bolus estimation. In particular alternative embodiments, the user's BG level is estimated using the last BG measurement, the age of the BG measurement, the amount of insulin that has been delivered, the insulin action time, the number of carbohydrates consumed, the carbohydrate/insulin ratio, and the like. In further alternative embodiments, the estimate of the user's BG level will expire if not used soon enough. In still further alternative embodiments, the estimate of the user's BG level may only be calculated for a certain period after a BG measurement is collected. In other alternative embodiments, the length of time that a BG estimate may be calculated since a BG measurement was collected is determined by the amount of insulin that has been delivered, the amount of carbohydrates the user has ingested, the user's insulin sensitivity, and/or by the user's insulin action time. For example, estimates of BG levels may be calculated for a longer period if the user has not eaten lately and is using only basal insulin. If the user has eaten or taken a bolus of insulin, then the period of time that an estimate of the user's BG level might be calculated is shorter.
  • [0060]
    In preferred embodiments, the BG meter 10 communicates with the infusion pump 50 using RF communication. In alternative embodiments, other modes of communication may be used, such as infrared (IR), wired, ultrasonic, sonic, optical, and the like. The BG meter 10 transmits one or more BG measurements to the infusion pump 50. The BG meter 10 may also communicate one or more remote control commands to the infusion pump 50. The available commands preferably include a bolus amount of insulin, a command to begin insulin delivery, and a command to suspend insulin delivery. In alternative embodiments, more or less remote control commands may be provided between the BG meter 10 and the infusion pump 50. The RF transmitter 15 (or RF transceiver 19 (as shown in FIG. 4(b)) or 36 (as shown in FIG. 5)) in the BG meter 10 transmits the data (e.g., BG measurements or remote control commands) to the RF communication system 60 in the infusion pump 50. Additionally, the infusion pump 50 may communicate one or more user-defined parameters to the BG meter 10 (e.g., the time required for a BG measurement to expire). The RF transceiver 81 in the infusion pump 50 (shown in FIG. 3(b)) transmits such parameters to the RF transceiver 19 (as shown in FIG. 4(b)) or 36 (as shown in FIG. 5) in the BG meter 10′ or 10″.
  • [0061]
    In preferred embodiments, communication between the BG meter 10 and the infusion pump 50 contains unique identifying information about the BG meter 10 and/or infusion pump 50, such as the BG meter's 10 and/or infusion pump's 50 serial number, identification number, a password, a code, or the like. In particular embodiments, the unique identifying information about the BG meter 10 and/or infusion pump 50 included in the communication between the BG meter 10 and the infusion pump 50 is used by the respective devices (i.e., BG meter 10 and/or infusion pump 50) to discern between communications that are intended for the device and those that are not. In alternative embodiments, other codes may be included in communications between the BG meter 10 and the infusion pump 50 that are used by the respective devices to recognize which communications are intended for the device, such as an identification code for the device, a password, a bit sequence, a special frequency, timing between communications, or the like.
  • [0062]
    In preferred embodiments, the communication system in the BG meter 10 may be deactivated, preferably by the user. When the communication system is deactivated, the BG meter 10 will not attempt to communicate with other devices, including the infusion pump 50. For example, when a new BG measurement is available, the BG meter 10 will not communicate the BG measurement to another device, such as the infusion pump 50. In particular embodiments, the BG meter 10 includes an RF transmitter 15 (shown in FIG. 4(a)) (or RF transceiver 19 (shown in FIG. 4(b)) or 36 (shown in FIG. 5)) that can be deactivated and reactivated by the user. This is especially useful if the BG meter 10 transmits at frequencies that might disrupt an airplane during take-off. In alternative embodiments, other devices may be used to deactivate and reactivate the communication system in the BG meter 10, such as the infusion pump 50, other insulin delivery device, a computer, PDA, portable telephone, or the like. In preferred embodiments, the BG meter 10 may be programmed to reactivate its communication system after a certain duration. In particular embodiments, when the user deactivates the BG meter's communication system, the user is prompted to enter a duration for how long communication system is to be deactivated, and the communication system will automatically become active at the end of the duration. In alternative embodiments, the user may specify a time of day for the communication system to become active. In particular embodiments, all of the BG measurements that have been generated while the communication system was deactivated are transmitted to the infusion pump 50 when the communication system is reactivated. Other data may also be transmitted to the infusion pump 50, such as the BG meter's clock time when the BG measurement was generated (i.e., the timestamp for the BG measurement), the age of the BG measurement, and the like.
  • [0063]
    One-way communication is preferably used between the BG meter 10 and the infusion pump 50. The BG meter 10 includes a transmitter 15, and the infusion pump 50 includes a receiver 80. For example, the BG meter 10 transmits data (e.g., BG measurements or remote control commands), and the infusion pump 50 receives this data. The benefits of one-way communication (compared to two-way) include cheaper unit costs, less development time, and decreased battery power requirements. However, the drawback of one-way communication is that there is no confirmation that the BG meter 10 has transmitted the data to the infusion pump 50. Accordingly, in alternative embodiments, two-way communication may be used, and the BG meter 10 may include a transceiver 19 (as shown in FIG. 4(b)) or 36 (as shown in FIG. 5), and the infusion pump 50 may include a transceiver 81 (as shown in FIG. 3(b)).
  • [0064]
    In preferred embodiments, the infusion pump 50 uses power cycling to periodically supply power to its communication system. In alternative embodiments, the infusion pump 50 may not use power cycling, and instead, may continuously supply power to its communication system. The power cycle, which is one period that the communication system is off plus one period that the communication system is on, is preferably 8 seconds. In alternative embodiments, the power cycle may be shorter or longer than 8 seconds, such as 2 or 4 seconds, 12 or 15 seconds, or the like. Further, the period that the communication system is on during each power cycle is preferably 48 milliseconds (ms). In alternative embodiments, the period that the communication system is on during each power cycle may be greater or less than 48 ms, depending on the length of the message to be received, the communication frequency, the speed of the communication system electronics, and the like. In preferred embodiments, the BG meter 10 sends repeated signals to the infusion pump 50 for a period longer than the power cycle. The signal sent from the BG meter 10 to the infusion pump 50 preferably includes a command that is short enough to be captured during the on-time of the infusion pump's communication system. In particular embodiments, the command is short enough to be captured multiple times (i.e., two, three, or more times) during the on-time of the infusion pump's communication system.
  • [0065]
    In preferred embodiments, the time that the infusion pump's communication system must be on to capture the command from the BG meter 10 is short compared to the power cycle. In further embodiments, the command is short compared to a string of information. When the infusion pump 50 receives a command, the infusion pump 50 stops power cycling the communication system and turns the communication system on continuously. Alternatively, when the infusion pump 50 receives a command, the infusion pump 50 may continue to use power cycling unless the command indicates that the pump 50 should prepare to receive a string of information. Thus, short commands may be used to activate the infusion pump's communication system so that one or more longer strings of information may be received by the infusion pump 50.
  • [0066]
    In particular embodiments, the infusion pump 50 prepares to receive a string of information longer than a command. The string of information preferably includes a BG measurement. The string of information may further include an elapsed time since the BG measurement was taken. In alternative embodiments, the string of information may include a clock time. In further alternative embodiments, the BG meter 10 may transmit a clock time to the infusion pump 50 so that the infusion pump 50 can determine the difference between the BG meter's clock and the infusion pump's clock. In other alternative embodiments, the infusion pump 50 may use the BG meter's clock time to reset the infusion pump's clock time.
  • [0067]
    In preferred embodiments, the infusion pump 50 returns to power cycling the communication system after information has been received from the BG meter 10. In particular embodiments, the infusion pump 50 returns to power cycling after it receives a complete signal containing a BG measurement from the BG meter 10. In alternative embodiments, the infusion pump 50 returns to power cycling at a predetermined period after a signal from the BG meter 10 has stopped. In other alternative embodiments, the infusion pump 50 returns to power cycling at a predetermined period after receiving a signal from the BG meter 10.
  • [0068]
    As described above, the infusion pump 50 preferably communicates with various external devices, such as the BG meter 10, using the RF communication system 60. In particular embodiments, the RF communication system 60 includes an RF receiver 80, an RF microcontroller 82 (RF PIC), and an application specific integrated circuit 84 (ASIC), as shown in FIG. 3(a). In other particular embodiments, the RF receiver 80 may be replaced with an RF transceiver 81, as shown in FIG. 3(b). The RF PIC 82 may hold a 7-byte word, although in alternative embodiments, the RF PIC 82 may hold other lengths of data. The processor 64 communicates with the RF PIC 82 and the ASIC 84 using synchronous peripheral interfaces (SPI interfaces).
  • [0069]
    The RF receiver 80 receives and demodulates RF signals, extracts a data packet from the RF signal, and passes the data packet to the RF PIC 82. The RF PIC 82 accepts and decodes the data packet and checks for format. If the format of the data packet is valid, the RF PIC 82 sends an interrupt signal to the ASIC 84. When the ASIC 84 receives an interrupt signal from the RF PIC 82, the ASIC 84 sends an interrupt to the processor 64, triggering the processor 64 to notify the RF PIC 82 to pass the contents of its buffer to the processor 64. The processor 64 acquires the decoded data packet from the RF PIC 82 and evaluates the content, which may include a command or information to be stored. In response to some data packets, the processor 64 will send a command to the ASIC 84 to change the power conditions on the RF receiver 80. The processor 64 also processes the commands and information received from the BG meter 10, which may result in changing the bolus delivery on the infusion pump 50 or entering a BG measurement into the bolus estimator 62. One of the main tasks for the ASIC 84 is to enable and disable power on the RF receiver 80. Generally, the ASIC 84 cycles the power on the RF receiver 80 to save energy. If commanded by the processor 64, however, the ASIC 84 will enable the RF receiver 80 to be powered continuously.
  • [0070]
    Each RF transmission sent to the pump preferably includes an RF signal header followed by a command packet or an information packet. Since the pump's RF receiver 80 is likely to wake up in the middle of a command packet, the RF signal header at the start of each transmission helps the pump 50 to synchronize its data sampling and identify the first byte of a new command packet or information packet. The RF signal header is preferably the same for each transmission, and is transmitted at the start of each RF transmission. The RF signal header may include two parts: a preamble and a start signature. The preamble is a series of pulses used to train the pump's digital signal sampling, and allows the pump 50 to synchronize its pulse sampling with the pulse bits in the new transmission. The start signature notifies the pump RF PIC 82 when the first byte of a new packet is starting. In alternative embodiments, the RF signal header may include other data. In further alternative embodiments, the RF signal header may be omitted.
  • [0071]
    In particular embodiments, command packets are 7 bytes in length, and information packets are 71 bytes in length. In alternative embodiments, the command packets and/or information packets may be of different lengths. The last byte of every command or information packet is an 8-bit cyclic redundancy check (CRC) calculated on all the preceding bytes in the packet. Before a command or information packet is sent by the BG meter 10 to the infusion pump 50, it is encoded using a DC balanced encoding scheme, which translates 4 bits of data into 6 for transmission as follows:
    HEX DC HEX DC
    0 010101 8 011010
    1 110001 9 011001
    2 110010 A 101010
    3 100011 B 001011
    4 110100 C 101100
    5 100101 D 001101
    6 100110 E 001110
    7 010110 F 011100
  • [0072]
    The result of the encoding is that the 7-byte command packets require transmission of 11 bytes and the 71-byte data packets require transmission of 107 bytes. Upon receipt of the 11-byte or 107-byte packets from the BG meter 10, the pump RF PIC 82 in the infusion pump 50 decodes the packet into the 7-byte command packet or the 71-byte information packet. The processor 64 then checks all packets for valid identification of the infusion pump 50 (e.g., identification or serial number) and CRC. If the identification of the infusion pump 50 is not valid, the packet is ignored. If the CRC of the first command packet is not valid, the command is ignored. Otherwise, the processor 64 sends a negative acknowledge (NAK) response to any packet with an invalid CRC.
  • [0073]
    Information packets (71 bytes) are much larger than command packets (7 bytes), and cannot be stored in the pump RF PIC 82, and thus, cannot be used to “wake up” the pump 50. Instead, a command packet must be sent to the pump 50 to turn on the pump's RF receiver 80 and prepare the pump 50 to receive an information packet. While power to the infusion pump's communication system (i.e. RF receiver 80) is being cycled, a command packet is repeatedly transmitted from the BG meter 10 to the infusion pump 50. If an RF signal (i.e. including the first command packet) is present when the pump's RF receiver 80 comes on, the pump 50 will attempt to store contents of the signal in the pump RF PIC 82. The processor 64 will verify whether the content of the signal is a valid command packet. If the command packet is valid, then the pump 50 will stop power cycling and power the RF receiver 80 continuously. Only the first command packet must be transmitted repeatedly. After the RF receiver 80 is on full-time, other command packets can be sent to the pump 50 in quick succession (for example, as quickly as the user can press buttons on the BG meter 10 or other external device to send the new command packets). Additional command packets or an information packet may also be transmitted to the pump 50.
  • [0074]
    The pump 50 preferably recognizes two categories of command packets: remote control or bolus commands and BG measurement commands. Remote control or bolus commands directly control the pump's insulin bolus delivery. BG measurement commands may transmit a new BG measurement(s) from the BG meter 10 to the pump 50, or alternatively, prepare the pump 50 to receive an information packet containing a new BG measurement value as well as other related data (e.g., a clock time or timestamp of the BG measurement, the age of the BG measurement, or the like) from the BG meter 10.
  • [0075]
    The pump 50 may receive a bolus command from the BG meter 10 or a remote programmer associated with the pump 50. The bolus command preferably includes a type code indicating the type of device transmitting the message (e.g., the BG meter 10 or the remote programmer), unique identifying information about the pump 50 (e.g., serial number, identification number, password, or the like), a key code indicating which bolus command button has been pressed (e.g., button “S” 22, button “B” 24, or button “ACT” 26 on the BG meter 10), and a counter indicating the number of times that the button has been pressed. In alternative embodiments, the bolus command may include other information and/or omit some of this data. When the pump 50 receives the bolus command, the processor 64 filters the command to discern the counter value so that the pump 50 can respond to the number of times the user has pressed the button to adjust a bolus.
  • [0076]
    The pump 50 may also receive a BG measurement command from the BG meter 10. The BG measurement command is transmitted to the pump 50 to send a new BG measurement(s) from the BG meter 10 to the pump 50, or alternatively, to prepare the pump 50 to receive an information packet containing a new BG measurement as well as other related data (e.g., a clock time or timestamp of the BG measurement, the age of the BG measurement, or the like) from the BG meter 10. If the BG measurement command transmits a new BG measurement(s) from the BG meter 10 to the infusion pump 50, the command preferably includes a type code indicating the type of device transmitting the message (e.g., the BG meter 10), the BG measurement value(s), and unique identifying information about the meter 10 and/or pump 50 (e.g., serial number, identification number, password, or the like). If the BG measurement command is transmitted to prepare the pump 50 to receive an information packet containing a BG measurement and other related data from the BG meter 10, the command preferably includes a type code indicating the type of device transmitting the message (e.g., the BG meter 10), unique identifying information about the meter 10 and/or pump 50 (e.g., serial number, identification number, password, or the like), and a key code indicating that a new BG measurement is about to be transmitted. In alternative embodiments, the BG measurement command may include other information and/or omit some of this data.
  • [0077]
    In response to communications from the BG meter 10, the pump 50 typically sends an acknowledge (ACK) response. However, in particular embodiments, the BG meter 10 does not include an RF receiver, and the pump 50 does not include an RF transmitter, and thus, the pump 50 does not send an ACK response if the type code in the command (e.g., bolus or BG measurement command) indicates that the device transmitting the message is the BG meter 10. In alternative embodiments, both the BG meter 10 and the pump 50 may include an RF transmitter and receiver (i.e. transceiver 19 (shown in FIG. 4(b)) or 36 (shown in FIG. 5) in the BG meter 10′ or 10″, and transceiver 81 (shown in FIG. 3(b)) in the infusion pump 50), and thus, the pump 50 may send an ACK response to the BG meter 10. Additionally, the pump 50 may send its clock time to the BG meter 10, and the BG meter 10 may use the pump's clock time to reset the BG meter's clock time if the devices' clock times do not correspond with one another. Further, if the meter 10 does not receive an ACK response from the pump 50, the meter 10 may attempt to retransmit the communication to the pump 50, either immediately or at a later time.
  • [0078]
    When the pump 50 receives a command packet from the BG meter 10, the processor 64 will send a data packet through the ASIC 84, commanding the RF receiver 80 to remain on full-time for a specified number of minutes, to receive other command packets or an information packet. The RF receiver 80 may return to power cycling after the information packet has been received, a certain period of time after receiving a BG measurement command (in the event that the anticipated information packet does not arrive), a certain period of time after receiving a bolus command, or after the battery in the pump 50 has been removed and replaced.
  • [0079]
    The pump RF PIC 82 remains in receive mode unless it has received a command to send from the processor 64, in which case it shall switch to transmit mode until the transmission is complete. Once the data has been transmitted, the pump RF PIC 82 automatically switches back to receive mode.
  • [0080]
    While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
  • [0081]
    The presently disclosed embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims, rather than the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3631847 *25 Mar 19694 Jan 1972James C HobbsMethod and apparatus for injecting fluid into the vascular system
US4270532 *13 Dec 19782 Jun 1981Siemens AktiengesellschaftDevice for the pre-programmable infusion of liquids
US4282872 *13 Dec 197811 Aug 1981Siemens AktiengesellschaftDevice for the pre-programmable infusion of liquids
US4373527 *27 Apr 197915 Feb 1983The Johns Hopkins UniversityImplantable, programmable medication infusion system
US4392849 *27 Jul 198112 Jul 1983The Cleveland Clinic FoundationInfusion pump controller
US4395259 *14 Sep 198126 Jul 1983Siemens AktiengesellschaftDevice for the infusion of fluids into the human or animal body
US4433072 *29 Apr 198321 Feb 1984Hospal-Sodip, S.A.Mixtures of polymers for medical use
US4443218 *9 Sep 198217 Apr 1984Infusaid CorporationProgrammable implantable infusate pump
US4469481 *16 Jun 19824 Sep 1984Terumo CorporationApparatus for infusing medication
US4475901 *6 Nov 19819 Oct 1984The Garvan Research Development Ltd.Apparatus for improving blood sugar control in diabetics
US4494950 *19 Jan 198222 Jan 1985The Johns Hopkins UniversityPlural module medication delivery system
US4529401 *11 Jan 198216 Jul 1985Cardiac Pacemakers, Inc.Ambulatory infusion pump having programmable parameters
US4542532 *9 Mar 198417 Sep 1985Medtronic, Inc.Dual-antenna transceiver
US4550731 *7 Mar 19845 Nov 1985Cordis CorporationAcquisition circuit for cardiac pacer
US4559037 *20 Jan 198417 Dec 1985Siemens AktiengesellschaftDevice for the pre-programmable infusion of liquids
US4562751 *6 Jan 19847 Jan 1986Nason Clyde KSolenoid drive apparatus for an external infusion pump
US4671288 *13 Jun 19859 Jun 1987The Regents Of The University Of CaliforniaElectrochemical cell sensor for continuous short-term use in tissues and blood
US4678408 *24 Sep 19857 Jul 1987Pacesetter Infusion, Ltd.Solenoid drive apparatus for an external infusion pump
US4685903 *6 Jan 198411 Aug 1987Pacesetter Infusion, Ltd.External infusion pump apparatus
US4696671 *11 Jun 198629 Sep 1987Omni-Flow, Inc.Infusion system having plural fluid input ports and at least one patient output port
US4703756 *6 May 19863 Nov 1987The Regents Of The University Of CaliforniaComplete glucose monitoring system with an implantable, telemetered sensor module
US4731051 *15 Feb 198315 Mar 1988The Johns Hopkins UniversityProgrammable control means for providing safe and controlled medication infusion
US4731726 *19 May 198615 Mar 1988Healthware CorporationPatient-operated glucose monitor and diabetes management system
US4781798 *8 May 19871 Nov 1988The Regents Of The University Of CaliforniaTransparent multi-oxygen sensor array and method of using same
US4803625 *30 Jun 19867 Feb 1989Buddy Systems, Inc.Personal health monitor
US4809697 *14 Oct 19877 Mar 1989Siemens-Pacesetter, Inc.Interactive programming and diagnostic system for use with implantable pacemaker
US4826810 *19 Mar 19872 May 1989Aoki Thomas TSystem and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof
US4865584 *16 Apr 198712 Sep 1989Omni-Flow, Inc.Cassette for programable multiple input infusion system
US4871351 *26 Aug 19873 Oct 1989Vladimir FeingoldImplantable medication infusion system
US4898578 *26 Jan 19886 Feb 1990Baxter International Inc.Drug infusion system with calculator
US4935105 *18 Oct 198919 Jun 1990Imperial Chemical Industries PlcMethods of operating enzyme electrode sensors
US4953552 *21 Apr 19894 Sep 1990Demarzo Arthur PBlood glucose monitoring system
US5019974 *22 Feb 199028 May 1991Diva Medical Systems BvDiabetes management system and apparatus
US5034004 *20 Jun 198823 Jul 1991The University Of MelbourneInfusion pump and drive systems therefor
US5050612 *12 Sep 198924 Sep 1991Matsumura Kenneth NDevice for computer-assisted monitoring of the body
US5078683 *4 May 19907 Jan 1992Block Medical, Inc.Programmable infusion system
US5080653 *16 Apr 199014 Jan 1992Pacesetter Infusion, Ltd.Infusion pump with dual position syringe locator
US5097122 *16 Apr 199017 Mar 1992Pacesetter Infusion, Ltd.Medication infusion system having optical motion sensor to detect drive mechanism malfunction
US5100380 *16 May 198931 Mar 1992Abbott LaboratoriesRemotely programmable infusion system
US5101814 *11 Aug 19897 Apr 1992Palti Yoram ProfSystem for monitoring and controlling blood glucose
US5108819 *14 Feb 199028 Apr 1992Eli Lilly And CompanyThin film electrical component
US5113869 *21 Aug 199019 May 1992Telectronics Pacing Systems, Inc.Implantable ambulatory electrocardiogram monitor
US5153827 *30 Jan 19896 Oct 1992Omni-Flow, Inc.An infusion management and pumping system having an alarm handling system
US5165407 *9 Apr 199124 Nov 1992The University Of KansasImplantable glucose sensor
US5211626 *17 Dec 199018 May 1993Product Innovation Holdings Ltd.Medical infusion apparatus
US5216597 *28 May 19911 Jun 1993Diva Medical Systems BvDiabetes therapy management system, apparatus and method
US5262035 *2 Aug 198916 Nov 1993E. Heller And CompanyEnzyme electrodes
US5262305 *3 Sep 199116 Nov 1993E. Heller & CompanyInterferant eliminating biosensors
US5264104 *8 May 199223 Nov 1993Gregg Brian AEnzyme electrodes
US5264105 *17 Mar 199323 Nov 1993Gregg Brian AEnzyme electrodes
US5266013 *25 Mar 199130 Nov 1993Asulab S.A.Portable pump for the administration of a therapeutic
US5904708 *19 Mar 199818 May 1999Medtronic, Inc.System and method for deriving relative physiologic signals
US6544212 *31 Jul 20018 Apr 2003Roche Diagnostics CorporationDiabetes management system
US7025743 *27 Mar 200311 Apr 2006Medtronic Minimed, Inc.External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US7278983 *22 Jul 20039 Oct 2007Medtronic Minimed, Inc.Physiological monitoring device for controlling a medication infusion device
US20020019606 *22 Jan 200114 Feb 2002Lebel Ronald J.Microprocessor controlled ambulatory medical apparatus with hand held communication device
US20030060765 *15 Feb 200127 Mar 2003Arthur CampbellInfusion device menu structure and method of using the same
US20030114836 *19 Dec 200119 Jun 2003Estes Mark C.Medication delivery system and monitor
US20030211617 *7 May 200213 Nov 2003International Business Machines CorporationBlood glucose meter that reminds the user to test after a hypoglycemic event
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7231263 *10 Oct 200612 Jun 2007Soo Bong ChoiMethod for controlling insulin pump through internet
US729110726 Aug 20046 Nov 2007Roche Diagnostics Operations, Inc.Insulin bolus recommendation system
US75532815 Oct 200730 Jun 2009Roche Diagnostices Operations, Inc.Insulin bolus recommendation system
US765495610 Mar 20052 Feb 2010Dexcom, Inc.Transcutaneous analyte sensor
US7704226 *17 Nov 200527 Apr 2010Medtronic Minimed, Inc.External infusion device with programmable capabilities to time-shift basal insulin and method of using the same
US771140222 Dec 20044 May 2010Dexcom, Inc.Device and method for determining analyte levels
US771357410 Mar 200511 May 2010Dexcom, Inc.Transcutaneous analyte sensor
US777414518 Jan 200610 Aug 2010Dexcom, Inc.Transcutaneous analyte sensor
US77786801 Aug 200317 Aug 2010Dexcom, Inc.System and methods for processing analyte sensor data
US778333310 Mar 200524 Aug 2010Dexcom, Inc.Transcutaneous medical device with variable stiffness
US779702814 Apr 200814 Sep 2010Dexcom, Inc.System and methods for processing analyte sensor data
US785776022 Feb 200628 Dec 2010Dexcom, Inc.Analyte sensor
US78605447 Mar 200728 Dec 2010Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US786054526 Feb 200828 Dec 2010Dexcom, Inc.Analyte measuring device
US786985123 Dec 200411 Jan 2011Roche Diagnostics Operations, Inc.System and method for determining insulin bolus quantities
US78698536 Aug 201011 Jan 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US787529310 May 200425 Jan 2011Dexcom, Inc.Biointerface membranes incorporating bioactive agents
US788569710 Mar 20058 Feb 2011Dexcom, Inc.Transcutaneous analyte sensor
US78856996 Aug 20108 Feb 2011Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US78968093 Nov 20081 Mar 2011Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US790583321 Jun 200515 Mar 2011Dexcom, Inc.Transcutaneous analyte sensor
US79144503 May 201029 Mar 2011Dexcom, Inc.System and methods for processing analyte sensor data
US79209077 Jun 20075 Apr 2011Abbott Diabetes Care Inc.Analyte monitoring system and method
US792532123 Mar 201012 Apr 2011Dexcom, Inc.System and methods for processing analyte sensor data
US792727429 Jul 200819 Apr 2011Dexcom, Inc.Integrated receiver for continuous analyte sensor
US793363923 Mar 201026 Apr 2011Dexcom, Inc.System and methods for processing analyte sensor data
US793505714 Jan 20093 May 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US794698410 Mar 200524 May 2011Dexcom, Inc.Transcutaneous analyte sensor
US794938111 Apr 200824 May 2011Dexcom, Inc.Transcutaneous analyte sensor
US795526123 Mar 20107 Jun 2011Dexcom, Inc.System and methods for processing analyte sensor data
US795956923 Mar 201014 Jun 2011Dexcom, Inc.System and methods for processing analyte sensor data
US79764926 Aug 200912 Jul 2011Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US797677822 Jun 200512 Jul 2011Abbott Diabetes Care Inc.Blood glucose tracking apparatus
US797910426 May 201012 Jul 2011Dexcom, Inc.System and methods for processing analyte sensor data
US798698623 Mar 201026 Jul 2011Dexcom, Inc.System and methods for processing analyte sensor data
US799807114 Oct 200916 Aug 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US80009019 Aug 201016 Aug 2011Dexcom, Inc.Transcutaneous analyte sensor
US800552514 Oct 200923 Aug 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US801017422 Aug 200330 Aug 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US801678910 Oct 200813 Sep 2011Deka Products Limited PartnershipPump assembly with a removable cover assembly
US803402610 Oct 200811 Oct 2011Deka Products Limited PartnershipInfusion pump assembly
US805260120 Aug 20088 Nov 2011Dexcom, Inc.System and methods for processing analyte sensor data
US80601731 Aug 200315 Nov 2011Dexcom, Inc.System and methods for processing analyte sensor data
US806225325 Apr 200622 Nov 2011Novo Nordisk A/SMedical skin mountable device
US806667210 Oct 200829 Nov 2011Deka Products Limited PartnershipInfusion pump assembly with a backup power supply
US807351914 Oct 20096 Dec 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US807352025 May 20106 Dec 2011Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US81132449 Feb 200714 Feb 2012Deka Products Limited PartnershipAdhesive and peripheral systems and methods for medical devices
US811563524 Nov 200914 Feb 2012Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US81174816 Jun 200814 Feb 2012Roche Diagnostics International AgApparatus and method for processing wirelessly communicated information within an electronic device
US811887717 Jan 200721 Feb 2012Dexcom, Inc.Porous membranes for use with implantable devices
US812856214 Oct 20096 Mar 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US81320376 Jun 20086 Mar 2012Roche Diagnostics International AgApparatus and method for processing wirelessly communicated data and clock information within an electronic device
US813317822 Feb 200613 Mar 2012Dexcom, Inc.Analyte sensor
US815048814 Oct 20093 Apr 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US816066911 Apr 200717 Apr 2012Dexcom, Inc.Transcutaneous analyte sensor
US816282930 Mar 200924 Apr 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US816780125 Mar 20101 May 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US817080310 Mar 20051 May 2012Dexcom, Inc.Transcutaneous analyte sensor
US81756739 Nov 20098 May 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US817771621 Dec 200915 May 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US81952659 Feb 20115 Jun 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US820629716 Dec 200926 Jun 2012Dexcom, Inc.System and methods for processing analyte sensor data
US82089849 Mar 201026 Jun 2012Smiths Medical Asd, Inc.Correction factor testing using frequent blood glucose input
US821613923 Sep 200910 Jul 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82192226 May 201010 Jul 2012Smiths Medical Asd, Inc.Expert system for pump therapy
US822134530 May 200717 Jul 2012Smiths Medical Asd, Inc.Insulin pump based expert system
US822302124 Nov 200917 Jul 2012Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US822302810 Oct 200817 Jul 2012Deka Products Limited PartnershipOcclusion detection system and method
US822441310 Oct 200817 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655518 Mar 200924 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655728 Dec 200924 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822655827 Sep 201024 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US822953426 Oct 200724 Jul 2012Dexcom, Inc.Transcutaneous analyte sensor
US822953520 Feb 200924 Jul 2012Dexcom, Inc.Systems and methods for blood glucose monitoring and alert delivery
US822953627 May 201024 Jul 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US82315311 Jun 200631 Jul 2012Dexcom, Inc.Analyte sensor
US823153230 Apr 200731 Jul 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US823395812 Oct 200931 Jul 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82339591 Sep 200631 Jul 2012Dexcom, Inc.Systems and methods for processing analyte sensor data
US823589621 Dec 20097 Aug 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US823624212 Feb 20107 Aug 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US82519047 Jun 200628 Aug 2012Roche Diagnostics Operations, Inc.Device and method for insulin dosing
US825190615 Apr 200928 Aug 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US825503117 Mar 200928 Aug 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US825725916 Oct 20084 Sep 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82603929 Jun 20084 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US826039313 Jun 20074 Sep 2012Dexcom, Inc.Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US826261610 Oct 200811 Sep 2012Deka Products Limited PartnershipInfusion pump assembly
US826572512 Oct 200911 Sep 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82657269 Nov 200911 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US826789210 Oct 200818 Sep 2012Deka Products Limited PartnershipMulti-language / multi-processor infusion pump assembly
US826824328 Dec 200918 Sep 2012Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US827302213 Feb 200925 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US827543723 Mar 200725 Sep 2012Dexcom, Inc.Transcutaneous analyte sensor
US82754399 Nov 200925 Sep 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US828047523 Feb 20092 Oct 2012Dexcom, Inc.Transcutaneous analyte sensor
US82825498 Dec 20049 Oct 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US828255029 Jul 20089 Oct 2012Dexcom, Inc.Integrated receiver for continuous analyte sensor
US828535423 Mar 20109 Oct 2012Dexcom, Inc.System and methods for processing analyte sensor data
US828745427 Sep 201016 Oct 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US828749510 Oct 201116 Oct 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US829055924 Oct 200816 Oct 2012Dexcom, Inc.Systems and methods for processing sensor data
US829056018 Nov 200816 Oct 2012Dexcom, Inc.Transcutaneous analyte sensor
US829056123 Sep 200916 Oct 2012Dexcom, Inc.Signal processing for continuous analyte sensor
US82905623 May 201016 Oct 2012Dexcom, Inc.System and methods for processing analyte sensor data
US829281027 Jan 201123 Oct 2012Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US82981727 Apr 200630 Oct 2012Novo Nordisk A/SMedical skin mountable device and system
US829818411 Oct 201130 Oct 2012Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US83065989 Nov 20096 Nov 2012Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US831174926 May 201113 Nov 2012Dexcom, Inc.Transcutaneous analyte sensor
US83134341 Mar 200720 Nov 2012Dexcom, Inc.Analyte sensor inserter system
US832114929 Jun 201127 Nov 2012Dexcom, Inc.Transcutaneous analyte sensor
US833200823 Mar 201011 Dec 2012Dexcom, Inc.System and methods for processing analyte sensor data
US834633618 Mar 20091 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US834633730 Jun 20091 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US834633827 Jan 20111 Jan 2013Dexcom, Inc.System and methods for replacing signal artifacts in a glucose sensor data stream
US834639920 Dec 20041 Jan 2013Tandem Diabetes Care, Inc.Programmable insulin pump
US835382921 Dec 200915 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US835709121 Dec 200922 Jan 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US835821024 Nov 200922 Jan 2013Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US836661430 Mar 20095 Feb 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US836991924 Oct 20085 Feb 2013Dexcom, Inc.Systems and methods for processing sensor data
US837200521 Dec 200912 Feb 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US837466716 Oct 200812 Feb 2013Dexcom, Inc.Signal processing for continuous analyte sensor
US838027311 Apr 200919 Feb 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US83860047 Sep 201126 Feb 2013Dexcom, Inc.Calibration techniques for a continuous analyte sensor
US839045524 Nov 20095 Mar 2013Abbott Diabetes Care Inc.RF tag on test strips, test strip vials and boxes
US839194517 Mar 20095 Mar 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US83940211 Oct 200712 Mar 2013Dexcom, Inc.System and methods for processing analyte sensor data
US839406011 Mar 201112 Mar 2013Novo Nordisk A/SVented drug reservoir unit
US84091317 Mar 20072 Apr 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US84123019 Feb 20112 Apr 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US84145229 Feb 20079 Apr 2013Deka Products Limited PartnershipFluid delivery systems and methods
US841452328 Oct 20109 Apr 2013Tandem Diabetes Care, Inc.Infusion pump with add-on modules
US841456331 Dec 20089 Apr 2013Deka Products Limited PartnershipPump assembly with switch
US841731224 Oct 20089 Apr 2013Dexcom, Inc.Systems and methods for processing sensor data
US842311324 Oct 200816 Apr 2013Dexcom, Inc.Systems and methods for processing sensor data
US842867926 Mar 201023 Apr 2013Dexcom, Inc.System and methods for processing analyte sensor data
US843517927 Jan 20117 May 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US844261021 Aug 200814 May 2013Dexcom, Inc.System and methods for processing analyte sensor data
US8444595 *15 Jun 200721 May 2013Animas CorporationMethods to pair a medical device and at least a remote controller for such medical device
US844952315 Jun 200728 May 2013Animas CorporationMethod of operating a medical device and at least a remote controller for such medical device
US845236814 Jan 200928 May 2013Dexcom, Inc.Transcutaneous analyte sensor
US84577085 Dec 20084 Jun 2013Dexcom, Inc.Transcutaneous analyte sensor
US846335014 May 201011 Jun 2013Dexcom, Inc.Transcutaneous analyte sensor
US846542530 Jun 200918 Jun 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US846988623 Sep 200925 Jun 2013Dexcom, Inc.Signal processing for continuous analyte sensor
US847302131 Jul 200925 Jun 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US84743976 May 20102 Jul 2013Dexcom, Inc.Transcutaneous analyte sensor
US847537317 Jul 20082 Jul 2013Dexcom, Inc.Transcutaneous analyte sensor
US848058019 Apr 20079 Jul 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US848379111 Apr 20089 Jul 2013Dexcom, Inc.Transcutaneous analyte sensor
US848379329 Oct 20109 Jul 2013Dexcom, Inc.Dual electrode system for a continuous analyte sensor
US849147427 Jan 201123 Jul 2013Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US849157031 Dec 200823 Jul 2013Deka Products Limited PartnershipInfusion pump assembly
US849664631 Dec 200830 Jul 2013Deka Products Limited PartnershipInfusion pump assembly
US850266230 Jun 20096 Aug 2013Animas CorporationMethod and system for using status indicators in wireless communication with medical devices
US850987128 Oct 200813 Aug 2013Dexcom, Inc.Sensor head for use with implantable devices
US851551610 Mar 200520 Aug 2013Dexcom, Inc.Transcutaneous analyte sensor
US851551926 Feb 200920 Aug 2013Dexcom, Inc.Transcutaneous analyte sensor
US854212217 Jan 201324 Sep 2013Abbott Diabetes Care Inc.Glucose measurement device and methods using RFID
US85454459 Feb 20071 Oct 2013Deka Products Limited PartnershipPatch-sized fluid delivery systems and methods
US854855114 May 20101 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US854855322 Jun 20121 Oct 2013Dexcom, Inc.System and methods for processing analyte sensor data
US85625585 Jun 200822 Oct 2013Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensor
US85658487 May 200922 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US856584914 May 201022 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US857162514 May 201029 Oct 2013Dexcom, Inc.Transcutaneous analyte sensor
US85853779 Feb 200719 Nov 2013Deka Products Limited PartnershipPumping fluid delivery systems and methods using force application assembly
US858888216 Dec 200919 Nov 2013Dexcom, Inc.System and methods for processing analyte sensor data
US859145520 Feb 200926 Nov 2013Dexcom, Inc.Systems and methods for customizing delivery of sensor data
US8593249 *17 Mar 200626 Nov 2013Phoniro AbMethod for unlocking a lock by a lock device enabled for short-range wireless data communication in compliance with a communication standard and associated device
US85971893 Mar 20093 Dec 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US861215916 Feb 200417 Dec 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US861528222 Feb 200624 Dec 2013Dexcom, Inc.Analyte sensor
US861707121 Jun 200731 Dec 2013Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US862290511 Dec 20097 Jan 2014Dexcom, Inc.System and methods for processing analyte sensor data
US862290621 Dec 20097 Jan 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US864161921 Dec 20094 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US86498413 Apr 200711 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US865204320 Jul 201218 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US865774516 Oct 200825 Feb 2014Dexcom, Inc.Signal processing for continuous analyte sensor
US86577475 Apr 201125 Feb 2014Dexcom, Inc.Systems and methods for processing analyte sensor data
US866062717 Mar 200925 Feb 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US866310929 Mar 20104 Mar 2014Dexcom, Inc.Transcutaneous analyte sensor
US866646916 Nov 20074 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US86686453 Jan 200311 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867081530 Apr 200711 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867284427 Feb 200418 Mar 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US867284525 Mar 201018 Mar 2014Dexcom, Inc.Systems and methods for processing analyte sensor data
US867628711 Dec 200918 Mar 2014Dexcom, Inc.System and methods for processing analyte sensor data
US868818830 Jun 20091 Apr 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US869077511 Apr 20088 Apr 2014Dexcom, Inc.Transcutaneous analyte sensor
US87001178 Dec 200915 Apr 2014Dexcom, Inc.System and methods for processing analyte sensor data
US870837610 Oct 200829 Apr 2014Deka Products Limited PartnershipMedium connector
US871894925 May 20126 May 2014Tandem Diabetes Care, Inc.Insulin pump with blood glucose modules
US872158530 Mar 201213 May 2014Dex Com, Inc.Integrated delivery device for continuous glucose sensor
US873163022 Mar 201020 May 2014Dexcom, Inc.Transcutaneous analyte sensor
US873434630 Apr 200727 May 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US873434817 Mar 200927 May 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US87381093 Mar 200927 May 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US87389572 Feb 201227 May 2014Roche Diagnostics Operations, Inc.Apparatus and method for processing a wirelessly received information encoded in form of embedded data and clock
US87445453 Mar 20093 Jun 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US874731523 Sep 200910 Jun 2014Dexcom. Inc.Signal processing for continuous analyte sensor
US874736325 Sep 201210 Jun 2014Novo Nordisk A/SMedical skin mountable device and system
US87509552 Nov 200910 Jun 2014Dexcom, Inc.Analyte sensor
US875832329 Jul 201024 Jun 2014Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US876185627 Apr 201224 Jun 2014Dexcom, Inc.System and methods for processing analyte sensor data
US876505927 Oct 20101 Jul 2014Abbott Diabetes Care Inc.Blood glucose tracking apparatus
US877118731 May 20118 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US877488724 Mar 20078 Jul 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US877488820 Jan 20108 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US87778534 Apr 201215 Jul 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US878800611 Dec 200922 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US87880078 Mar 201222 Jul 2014Dexcom, Inc.Transcutaneous analyte sensor
US878800831 May 201122 Jul 2014Dexcom, Inc.System and methods for processing analyte sensor data
US879026014 Oct 200929 Jul 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US879295319 Mar 201029 Jul 2014Dexcom, Inc.Transcutaneous analyte sensor
US879517714 Jan 20095 Aug 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US880161024 Jul 200912 Aug 2014Dexcom, Inc.Signal processing for continuous analyte sensor
US880161227 Apr 201212 Aug 2014Dexcom, Inc.System and methods for processing analyte sensor data
US880165720 Oct 201012 Aug 2014Tandem Diabetes Care, Inc.Pump with therapy coaching
US880818227 Apr 201219 Aug 2014Dexcom, Inc.System and methods for processing analyte sensor data
US88082285 Jun 200819 Aug 2014Dexcom, Inc.Integrated medicament delivery device for use with continuous analyte sensor
US881207217 Apr 200819 Aug 2014Dexcom, Inc.Transcutaneous medical device with variable stiffness
US88120731 Jun 201019 Aug 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US88214009 Feb 20112 Sep 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US882512714 May 20102 Sep 2014Dexcom, Inc.Transcutaneous analyte sensor
US88405528 Dec 200923 Sep 2014Dexcom, Inc.Membrane for use with implantable devices
US884055326 Feb 200923 Sep 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US884058229 May 201223 Sep 2014Tandem Diabetes Care, Inc.Infusion pump with activity monitoring
US88431871 Jun 201023 Sep 2014Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US884553611 Apr 200730 Sep 2014Dexcom, Inc.Transcutaneous analyte sensor
US885843410 Mar 200514 Oct 2014Dexcom, Inc.Transcutaneous analyte sensor
US888013718 Apr 20034 Nov 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US888627222 Feb 200611 Nov 2014Dexcom, Inc.Analyte sensor
US88862737 Nov 200811 Nov 2014Dexcom, Inc.Analyte sensor
US89158493 Feb 200923 Dec 2014Dexcom, Inc.Transcutaneous analyte sensor
US891585028 Mar 201423 Dec 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US892031928 Dec 201230 Dec 2014Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US892656129 Jul 20106 Jan 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US892658530 Mar 20126 Jan 2015Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US8932250 *15 Jun 200713 Jan 2015Animas CorporationSystems and methods to pair a medical device and a remote controller for such medical device
US89743861 Nov 200510 Mar 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US898620913 Jul 201224 Mar 2015Dexcom, Inc.Transcutaneous analyte sensor
US898983310 Mar 200524 Mar 2015Dexcom, Inc.Transcutaneous analyte sensor
US901133129 Dec 200421 Apr 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US901133230 Oct 200721 Apr 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US90147737 Mar 200721 Apr 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US902057210 Sep 201028 Apr 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US904173011 Feb 201126 May 2015Dexcom, Inc.Receivers for analyzing and displaying sensor data
US90429532 Mar 200726 May 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US904419910 Mar 20052 Jun 2015Dexcom, Inc.Transcutaneous analyte sensor
US904998230 Mar 20119 Jun 2015Animas CorporationMethods to pair a medical device and at least a remote controller for such medical device
US905590114 Sep 201216 Jun 2015Dexcom, Inc.Transcutaneous analyte sensor
US90666943 Apr 200730 Jun 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906669512 Apr 200730 Jun 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US906669727 Oct 201130 Jun 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US907247721 Jun 20077 Jul 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US907860717 Jun 201314 Jul 2015Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US910762315 Apr 200918 Aug 2015Dexcom, Inc.Signal processing for continuous analyte sensor
US913540224 Oct 200815 Sep 2015Dexcom, Inc.Systems and methods for processing sensor data
US914356920 Feb 200922 Sep 2015Dexcom, Inc.Systems and methods for processing, transmitting and displaying sensor data
US91492199 Feb 20116 Oct 2015Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US914923313 Jun 20126 Oct 2015Dexcom, Inc.Systems and methods for processing sensor data
US914923413 Jun 20126 Oct 2015Dexcom, Inc.Systems and methods for processing sensor data
US917399621 Sep 20063 Nov 2015Deka Products Limited PartnershipInfusion set for a fluid pump
US918024510 Oct 200810 Nov 2015Deka Products Limited PartnershipSystem and method for administering an infusible fluid
US919232823 Sep 200924 Nov 2015Dexcom, Inc.Signal processing for continuous analyte sensor
US921137729 Jul 201015 Dec 2015Tandem Diabetes Care, Inc.Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US92479004 Jun 20132 Feb 2016Dexcom, Inc.Analyte sensor
US92479012 Aug 20062 Feb 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US928292525 Mar 201015 Mar 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US932671429 Jun 20103 May 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US93267165 Dec 20143 May 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US932837116 Jul 20133 May 2016Dexcom, Inc.Sensor head for use with implantable devices
US933023724 Dec 20083 May 2016Medtronic Minimed, Inc.Pattern recognition and filtering in a therapy management system
US933923816 May 201217 May 2016Dexcom, Inc.Systems and methods for processing sensor data
US935166812 Oct 200931 May 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US936417323 Sep 200914 Jun 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US939167030 Sep 201312 Jul 2016Animas CorporationMethods for secure communication and pairing of a medical infusion device and a remote controller for such medical device
US941477710 Mar 200516 Aug 2016Dexcom, Inc.Transcutaneous analyte sensor
US94209651 Jul 201123 Aug 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US94209684 Apr 201223 Aug 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US942718312 Jul 201130 Aug 2016Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US945190819 Dec 201227 Sep 2016Dexcom, Inc.Analyte sensor
US947781123 Jun 200525 Oct 2016Abbott Diabetes Care Inc.Blood glucose tracking apparatus and methods
US948657123 Dec 20148 Nov 2016Tandem Diabetes Care, Inc.Safety processor for wireless control of a drug delivery device
US949815516 Oct 200822 Nov 2016Dexcom, Inc.Signal processing for continuous analyte sensor
US949815930 Oct 200722 Nov 2016Abbott Diabetes Care Inc.Analyte monitoring device and methods of use
US94981645 Dec 201322 Nov 2016Dexcom, Inc.Receivers for analyzing and displaying sensor data
US94981655 Dec 201322 Nov 2016Dexcom, Inc.Receivers for analyzing and displaying sensor data
US20040215492 *24 May 200428 Oct 2004Choi Soo BongMethod for controlling insulin pump through internet
US20050027181 *1 Aug 20033 Feb 2005Goode Paul V.System and methods for processing analyte sensor data
US20050090607 *28 Oct 200328 Apr 2005Dexcom, Inc.Silicone composition for biocompatible membrane
US20050112169 *22 Aug 200326 May 2005Dexcom, Inc.Porous membranes for use with implantable devices
US20050137573 *17 Dec 200423 Jun 2005Animas CorporationSystem, method, and communication hub for controlling external infusion device
US20050154271 *17 Nov 200414 Jul 2005Andrew RasdalIntegrated receiver for continuous analyte sensor
US20050192557 *26 Feb 20041 Sep 2005DexcomIntegrated delivery device for continuous glucose sensor
US20060020187 *10 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US20060020189 *10 Mar 200526 Jan 2006Dexcom, Inc.Transcutaneous analyte sensor
US20060036139 *10 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US20060036141 *10 Mar 200516 Feb 2006Dexcom, Inc.Transcutaneous analyte sensor
US20060137695 *23 Dec 200429 Jun 2006Robert HellwigSystem and method for determining insulin bolus quantities
US20060264835 *25 Apr 200623 Nov 2006Novo Nordisk A/SMedical skin mountable device
US20070032891 *10 Oct 20068 Feb 2007Choi Soo BMethod for controlling insulin pump through internet
US20070066873 *1 Sep 200622 Mar 2007Apurv KamathSystems and methods for processing analyte sensor data
US20070078818 *7 Jun 20065 Apr 2007Roche Diagnostics Operations, Inc.Device and method for insulin dosing
US20070112298 *17 Nov 200517 May 2007Medtronic Minimed, Inc.External infusion device with programmable capabilities to time-shift basal insulin and method of using the same
US20070229257 *16 Mar 20074 Oct 2007Olle BlidingWake-up device and method for generating a control signal
US20070232879 *3 May 20074 Oct 2007Mark BristerTranscutaneous analyte sensor
US20070233051 *31 Mar 20064 Oct 2007David HohlDrug delivery systems and methods
US20070265515 *3 May 200715 Nov 2007Mark BristerTranscutaneous analyte sensor
US20080020794 *23 Apr 200724 Jan 2008Mark GaronMobile electronic device with fluid delivery system
US20080058628 *5 Oct 20076 Mar 2008Robert HellwigInsulin bolus recommendation system
US20080133146 *15 Dec 20055 Jun 2008Chang Kc Shu KunDevice Having a Trend-Indicating Display
US20080194937 *14 Apr 200814 Aug 2008Dexcom, Inc.System and methods for processing analyte sensor data
US20080195967 *14 Apr 200814 Aug 2008Dexcom, Inc.System and methods for processing analyte sensor data
US20080214919 *12 Dec 20074 Sep 2008Lifescan, Inc.System and method for implementation of glycemic control protocols
US20080228056 *13 Mar 200718 Sep 2008Michael BlomquistBasal rate testing using frequent blood glucose input
US20080256738 *23 Apr 200723 Oct 2008Malone Randolph WFrameless, Heated Wiper Assembly And System Utilizing Same
US20080262469 *5 Jun 200823 Oct 2008Dexcom. Inc.Integrated medicament delivery device for use with continuous analyte sensor
US20080287870 *17 Oct 200620 Nov 2008Nov Nordisk A/SVented Drug Reservoir Unit
US20080300534 *30 May 20074 Dec 2008Michael BlomquistInsulin pump based expert system
US20080306443 *6 Jun 200711 Dec 2008Mallinckrodt Inc.Medical Fluid Injector Having Wireless Pressure Monitoring Feature
US20080312512 *15 Jun 200718 Dec 2008Animas CorporationMethods to pair a medical device and at least a remote controller for such medical device
US20080312584 *15 Jun 200718 Dec 2008Animas CorporationSystems and methods to pair a medical device and a remote controller for such medical device
US20080312585 *15 Jun 200718 Dec 2008Animas CorporationMethod of operating a medical device and at least a remote controller for such medical device
US20090118592 *8 Dec 20067 May 2009Novo Nordisk A/SMedical System Comprising a Sensor Device
US20090118682 *13 Sep 20067 May 2009Novo Nordisk A/SReservoir Device With Inspection Aid For Detection Of Drug Condition
US20090124877 *14 Jan 200914 May 2009Dexcom, Inc.Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20090131860 *7 Apr 200621 May 2009Novo Nordisk A/SMedical Skin Mountable Device And System
US20090177154 *8 Jan 20089 Jul 2009Michael BlomquistInsulin pump with convenience features
US20090184801 *17 Mar 200623 Jul 2009Olle BlidingMethod for Unlocking a Lock by a Lock Device Enabled for Short-Range Wireless Data Communication in Compliance With a Communication Standard and Associated Device
US20090216103 *7 May 200927 Aug 2009Dexcom, Inc.Transcutaneous analyte sensor
US20090240385 *2 Mar 200924 Sep 2009Denso CorporationElectronic control apparatus for vehicle
US20090271021 *23 Apr 200929 Oct 2009Popp Shane MExecution system for the monitoring and execution of insulin manufacture
US20090299276 *6 Aug 20093 Dec 2009Dexcom, Inc.Integrated delivery device for continuous glucose sensor
US20090305317 *19 May 200910 Dec 2009Brauer Jacob SUser interface for testing device
US20090307520 *6 Jun 200810 Dec 2009Bruno AnselmiApparatus and Method for Processing Wirelessly Communicated Information Within an Electronic Device
US20090326722 *30 Jun 200931 Dec 2009Animas CorporationMethod and System for Using Status Indicators in Wireless Communication with Medical Devices
US20100030485 *12 Oct 20094 Feb 2010Dexcom, Inc.Signal processing for continuous analyte sensor
US20100100048 *14 Oct 200922 Apr 2010Novo Nordisk A/SMedical Skin Mountable Device
US20100222765 *9 Mar 20102 Sep 2010Smiths Medical Asd, Inc.Correction factor testing using frequent blood glucose input
US20100274751 *6 May 201028 Oct 2010Smith Medical Asd, Inc.Expert system for insulin pump therapy
US20110014954 *7 Jan 201020 Jan 2011Dossas Vasilios DEmergency Medical Diagnosis and Communications Device
US20110033833 *20 Oct 201010 Feb 2011Michael BlomquistPump with therapy coaching
US20110040251 *28 Oct 201017 Feb 2011Michael BlomquistInfusion pump with add-on modules
US20110137255 *14 Feb 20119 Jun 2011Novo Nordisk A/SMedical Skin Mountable Device
US20110160670 *11 Mar 201130 Jun 2011Novo Nordisk A/SVented drug reservoir unit
US20110178499 *30 Mar 201121 Jul 2011Animas CorporationMethods to pair a medical device and at least a remote controller for such medical device
US20110201911 *11 Feb 201118 Aug 2011Dexcom, Inc.Receivers for analyzing and displaying sensor data
US20110208013 *24 Feb 201025 Aug 2011Edwards Lifesciences CorporationBody Parameter Sensor and Monitor Interface
US20110282173 *29 Aug 200817 Nov 2011Brighter AbPortable medical apparatus
USRE446951 May 20127 Jan 2014Dexcom, Inc.Dual electrode system for a continuous analyte sensor
EP2140893A130 Jun 20096 Jan 2010Animas CorporationSystem for using status indicators in wireless communications with medical devices
EP2502641A230 Jun 200926 Sep 2012Animas CorporationA method and system for using status indicators in wireless communications with medical devices
WO2006066038A2 *15 Dec 200522 Jun 2006Bayer Healthcare LlcAnalyte test device having a trend-indicating display
WO2006066038A3 *15 Dec 20053 Aug 2006Bayer Healthcare LlcAnalyte test device having a trend-indicating display
WO2006108809A17 Apr 200619 Oct 2006Novo Nordisk A/SMedical skin mountable device and system
WO2009089028A2 *8 Jan 200916 Jul 2009Smiths Medical Md, Inc.Insulin pump with convenience features
WO2009146379A1 *28 May 20093 Dec 2009Pelikan Technologies, Inc.Devices and methods for glucose measurement using rechargeable battery energy sources
Classifications
U.S. Classification604/154
International ClassificationA61B5/00, A61M5/142, A61M5/14
Cooperative ClassificationA61M2205/3576, A61M2230/201, A61B5/0002, A61M5/14244, A61B5/14532, A61M2205/3584, A61M2005/1405
European ClassificationA61M5/142P, A61B5/00B
Legal Events
DateCodeEventDescription
17 Nov 2003ASAssignment
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ESTES, MARK C.;TALBOT, CARY D.;TOLLE, MIKE CHARLES VALLET;AND OTHERS;REEL/FRAME:014723/0738;SIGNING DATES FROM 20031016 TO 20031029